10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 0-26946

INTEVAC, INC.

(Exact name of registrant as specified in its charter)

Delaware	94-3125814
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

3560 Bassett Street

Santa Clara, California 95054

(Address of principal executive office, including Zip Code)

Registrant’s telephone number, including area code: (408) 986-9888

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒  Yes    ☐  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).   ☒    Yes    ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and emerging growth company in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐  (Do not check if a smaller reporting company)	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  ☐  Yes    ☒  No

On October 31, 2017, 21,789,007 shares of the Registrant’s Common Stock, $0.001 par value, were outstanding.

INTEVAC, INC.

INDEX

No.		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Balance Sheets		3
	Condensed Consolidated Statements of Operations		4
	Condensed Consolidated Statements of Comprehensive Income (Loss)		5
	Condensed Consolidated Statements of Cash Flows		6
	Notes to Condensed Consolidated Financial Statements		7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		22
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		29
Item 4.	Controls and Procedures		30
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings		31
Item 1A.	Risk Factors		31
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		38
Item 3.	Defaults upon Senior Securities		38
Item 4.	Mine Safety Disclosures		39
Item 5.	Other Information		39
Item 6.	Exhibits		39
SIGNATURES			40

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

INTEVAC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2017			December 31, 2016
	(Unaudited)
	(In thousands, except par value)
ASSETS
Current assets:
Cash and cash equivalents	$	19,197		$	27,043
Short-term investments		18,037			17,602
Trade and other accounts receivable, net of allowances of $0 at both September 30, 2017 and at December 31, 2016		22,311			17,447
Inventories		32,581			24,876
Prepaid expenses and other current assets		2,825			1,768
Total current assets		94,951			88,736
Property, plant and equipment, net		12,509			11,237
Long-term investments		6,165			3,593
Restricted cash		1,400			1,602
Intangible assets, net of amortization of $6,725 at September 30, 2017 and $6,129 at December 31, 2016		1,662			2,258
Deferred income taxes and other long-term assets		745			898
Total assets	$	117,432		$	108,324
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,036		$	5,323
Accrued payroll and related liabilities		5,781			4,220
Other accrued liabilities		7,856			17,011
Customer advances		12,347			5,422
Total current liabilities		33,020			31,976
Other long-term liabilities		2,994			3,082
Stockholders’ equity:
Common stock, $0.001 par value		22			21
Additional paid-in capital		176,282			171,314
Treasury stock, 4,845 shares at both September 30, 2017 and December 31, 2016		(28,489	)		(28,489	)
Accumulated other comprehensive income		443			321
Accumulated deficit		(66,840	)		(69,901	)
Total stockholders’ equity		81,418			73,266
Total liabilities and stockholders’ equity	$	117,432		$	108,324

Note: Amounts as of December 31, 2016 are derived from the December 31, 2016 audited consolidated financial statements.

See accompanying notes to the condensed consolidated financial statements.

3

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended					Nine Months Ended
	September 30, 2017		October 1, 2016			September 30, 2017		October 1, 2016
	(Unaudited)
	(In thousands, except per share amounts)
Net revenues:
Systems and components	$	24,537	$	20,961		$	82,822	$	47,326
Technology development		2,189		1,598			5,255		3,816
Total net revenues		26,726		22,559			88,077		51,142
Cost of net revenues:
Systems and components		13,402		13,025			47,419		29,490
Technology development		2,026		1,019			4,842		3,155
Total cost of net revenues		15,428		14,044			52,261		32,645
Gross profit		11,298		8,515			35,816		18,497
Operating expenses:
Research and development		4,535		4,067			13,635		14,220
Selling, general and administrative		5,495		4,772			17,482		14,724
Total operating expenses		10,030		8,839			31,117		28,944
Income (loss) from operations		1,268		(324	)		4,699		(10,447	)
Interest income and other income (expense), net		28		60			265		184
Income (loss) before income taxes		1,296		(264	)		4,964		(10,263	)
Provision for income taxes		66		217			805		13
Net income (loss)	$	1,230	$	(481	)	$	4,159	$	(10,276	)
Net income (loss) per share:
Basic	$	0.06	$	(0.02	)	$	0.19	$	(0.50	)
Diluted	$	0.05	$	(0.02	)	$	0.18	$	(0.50	)
Weighted average common shares outstanding:
Basic		21,714		20,869			21,475		20,704
Diluted		22,970		20,869			22,989		20,704

See accompanying notes to the condensed consolidated financial statements.

4

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

	Three Months Ended					Nine Months Ended
	September 30, 2017		October 1, 2016			September 30, 2017		October 1, 2016
	(Unaudited)
	(In thousands)
Net income (loss)	$	1,230	$	(481	)	$	4,159	$	(10,276	)
Other comprehensive income (loss), before tax
Change in unrealized net gain on available-for-sale investments		5		(16	)		8		41
Foreign currency translation gains (losses)		39		(17	)		114		5
Other comprehensive income (loss), before tax		44		(33	)		122		46
Income tax (expense) benefit related to items in other comprehensive income (loss)		—		—			—		—
Other comprehensive income (loss), net of tax		44		(33	)		122		46
Comprehensive income (loss)	$	1,274	$	(514	)	$	4,281	$	(10,230	)

See accompanying notes to the condensed consolidated financial statements.

5

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine months ended
	September 30, 2017			October 1, 2016
	(Unaudited)
	(In thousands)
Operating activities
Net income (loss)	$	4,159		$	(10,276	)
Adjustments to reconcile net income (loss) to net cash and cash equivalents used in operating activities:
Depreciation and amortization		2,877			3,744
Net amortization of investment premiums and discounts		53			96
Equity-based compensation		3,012			2,896
Change in the fair value of acquisition-related contingent consideration		(181	)		(90	)
Deferred income taxes		(1	)		9
Gain on disposal of equipment		—			(8	)
Changes in operating assets and liabilities		(11,658	)		577
Total adjustments		(5,898	)		7,224
Net cash and cash equivalents used in operating activities		(1,739	)		(3,052	)
Investing activities
Purchases of investments		(21,968	)		(10,433	)
Proceeds from sales and maturities of investments		18,916			22,180
Proceeds from sale of equipment		—			8
Purchases of leasehold improvements and equipment		(3,553	)		(2,535	)
Decrease (increase) in restricted cash		202			(178	)
Net cash and cash equivalents (used in) provided by investing activities		(6,403	)		9,042
Financing activities
Net proceeds from issuance of common stock		2,344			1,482
Taxes paid related to net share settlement		(1,988	)		(403	)
Payment of acquisition-related contingent consideration		(174	)		—
Net cash and cash equivalents provided by financing activities		182			1,079
Effect of exchange rate changes on cash		114			8
Net increase (decrease) in cash and cash equivalents		(7,846	)		7,077
Cash and cash equivalents at beginning of period		27,043			13,746
Cash and cash equivalents at end of period	$	19,197		$	20,823

See accompanying notes to the condensed consolidated financial statements.

6

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Basis of Presentation

In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac, Inc. and its subsidiaries (“Intevac” or the “Company”) included herein have been prepared on a basis consistent with the December 31, 2016 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in Intevac’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (“2016 Form 10-K”). Intevac’s results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of future operating results.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates.

2. Recent Accounting Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Compensation—Stock Compensation: Scope of Modification Accounting, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. An entity will account for the effects of a modification unless the fair value of the modified award is the same as the original award, the vesting conditions of the modified award are the same as the original award and the classification of the modified award as an equity instrument or liability instrument is the same as the original award. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2019. The update is to be adopted prospectively to an award modified on or after the adoption date. Early adoption is permitted. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.

In March 2017, the FASB issued ASU 2017-08, Receivables – Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium, shortening such period to the earliest call date. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2019. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates Step 2 from the goodwill impairment test. Under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.

7

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

In March 2016, the FASB issued ASU 2016-09 Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. We have adopted these amendments beginning in the first quarter of 2017. Starting in the first quarter of fiscal 2017, stock-based compensation excess tax benefits or deficiencies are reflected in the Condensed Consolidated Statements of Operations as a component of the provision for income taxes, whereas they previously were recognized in equity. Additionally, our Condensed Consolidated Statements of Cash Flows now presents excess tax benefits as an operating activity. Finally, we have elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The net cumulative effect of this change was recognized as a $1.1 million charge to the accumulated deficit as of January 1, 2017.

In May 2014, the FASB issued ASU 2014-09 (Topic 606) Revenue from Contracts with Customers. Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, “Revenue Recognition”, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We expect revenue recognition for our equipment sales arrangements, which includes systems, technology upgrades, service and spare parts, to remain materially consistent with our historical practice.

We expect to recognize revenue for equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. Our contracts with customers may include multiple performance obligations. For such arrangements, we expect to allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the prices charged to customers or using expected cost plus margin. The expected costs associated with our base warranties will continue to be recognized as expense when the equipment is sold.

We expect to recognize revenue for cost plus fixed fee and firm fixed priced government contracts over time under the cost-to-cost method for the majority of our government contracts, which is consistent with our current revenue recognition model. Revenue on the majority of our government contracts will continue to be recognized over time because of the continuous transfer of control to the customer. For U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. Similarly, for non-U.S. government contracts, the customer typically controls the work in process as evidenced either by contractual termination clauses or by our rights to payment for work performed to date to deliver products or services that do not have an alternative use to the company. Under the new standard, the cost-to-cost measure of progress continues to best depict the transfer of control of assets to the customer, which occurs as we incur costs.

The new standard must be adopted by Intevac in our fiscal year beginning December 31, 2017. We intend to adopt the new standard as of December 31, 2017, using the modified retrospective transition method applied to those contracts which were not completed as of that date. Upon adoption, we will recognize the cumulative effect of adopting this guidance as an adjustment to our opening balance of the accumulated deficit. Prior periods will not be retrospectively adjusted. Based on our preliminary assessment, we expect the adoption of Topic 606 will not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated Statements of Operations. We also do not expect the standard to have a material impact on our Consolidated Balance Sheet. The immaterial impact primarily relates to reclassifications among financial statement accounts to align with the new standard. Most notably, contracts in process, net will be reclassified as receivables or contract assets based on amounts billed or unbilled, respectively. Advance payments and billings in excess of costs incurred and deferred revenue will be combined and reclassified as contract liabilities. Our contract balances will be reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.

8

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

3. Inventories

Inventories are stated at the lower of average cost or market and consist of the following:

	September 30,		December 31,
	2017		2016
	(In thousands)
Raw materials	$	16,385	$	10,290
Work-in-progress		12,452		6,470
Finished goods		3,744		8,116
	$	32,581	$	24,876

Finished goods inventory consists primarily of completed systems that are undergoing installation and acceptance testing.

4. Equity-Based Compensation

At September 30, 2017, Intevac had equity-based awards outstanding under the 2012 Equity Incentive Plan and the 2004 Equity Incentive Plan (together, the “Plans”) and the 2003 Employee Stock Purchase Plan (the “ESPP”). Intevac’s stockholders approved all of these plans. The Plans permit the grant of incentive or non-statutory stock options, restricted stock, stock appreciation rights, restricted stock units (“RSUs”) and performance shares.

The ESPP provides that eligible employees may purchase Intevac’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market value at the entry date of the applicable offering period or at the end of each applicable purchase interval. Offering periods are generally two years in length, and consist of a series of six-month purchase intervals. Eligible employees may join the ESPP at the beginning of any six-month purchase interval. Under the terms of the ESPP, employees can choose to have up to 15% of their base earnings withheld to purchase Intevac common stock.

Compensation Expense

The effect of recording equity-based compensation for the three and nine months ended September 30, 2017 and October 1, 2016 was as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Equity-based compensation by type of award:
Stock options	$	350	$	211	$	808	$	696
RSUs		731		543		1,943		1,657
ESPP awards		67		151		261		543
Total equity-based compensation	$	1,148	$	905	$	3,012	$	2,896

Equity-based compensation expense is based on awards ultimately expected to vest and such amount has been historically reduced for estimated forfeitures. Beginning January 1, 2017, Intevac accounts for forfeitures as they occur, rather than estimating expected forfeitures. The net cumulative effect of this change was recognized as a $1.1 million increase to the accumulated deficit as of January 1, 2017.

9

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Stock Options and ESPP

The fair value of stock options and ESPP awards is estimated at the grant date using the Black-Scholes option valuation model. The determination of fair value of stock options and ESPP awards on the date of grant using an option-pricing model is affected by Intevac’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards and actual employee stock option exercise behavior.

Option activity as of September 30, 2017 and changes during the nine months ended September 30, 2017 were as follows:

	Shares			Weighted Average Exercise Price
Options outstanding at December 31, 2016		2,740,364		$	7.00
Options granted		413,075		$	12.33
Options cancelled and forfeited		(61,753	)	$	12.07
Options exercised		(115,273	)	$	6.88
Options outstanding at September 30, 2017		2,976,413		$	7.64
Options exercisable at September 30, 2017		2,127,940		$	7.16

Intevac issued 405,659 shares under the ESPP during the nine months ended September 30, 2017.

Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
Stock Options:
Weighted-average fair value of grants per share	$	3.89		$	1.90		$	4.54		$	1.75
Expected volatility		42.10	%		40.53	%		40.54	%		44.00	%
Risk free interest rate		1.84	%		0.97	%		1.77	%		0.94	%
Expected term of options (in years)		4.08			3.96			4.10			4.29
Dividend yield		None			None			None			None
	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
Stock Purchase Rights:
Weighted-average fair value of grants per share	$	2.76		$	1.69		$	2.75		$	1.55
Expected volatility		48.59	%		37.51	%		43.51	%		39.22	%
Risk free interest rate		1.36	%		0.63	%		1.22	%		0.75	%
Expected term of purchase rights (in years)		0.50			1.00			0.65			1.87
Dividend yield		None			None			None			None

10

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The computation of the expected volatility assumptions used in the Black-Scholes calculations for new stock option grants and employee stock purchase rights is based on the historical volatility of Intevac’s stock price, measured over a period equal to the expected term of the stock option grant or purchase right. The risk-free interest rate is based on the yield available on U.S. Treasury Strips with an equivalent remaining term. The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the equity-based awards and vesting schedules. The expected term of purchase rights represents the period of time remaining in the current offering period. The dividend yield assumption is based on Intevac’s history of not paying dividends and the assumption of not paying dividends in the future.

RSUs

A summary of the RSU activity is as follows:

	Shares			Weighted Average Grant Date Fair Value
Non-vested RSUs at December 31, 2016		949,455		$	4.64
Granted		363,846		$	11.44
Vested		(500,621	)	$	4.46
Cancelled and forfeited		(14,292	)	$	7.97
Non-vested RSUs at September 30, 2017		798,388		$	7.79

Time-based RSUs are converted into shares of Intevac common stock upon vesting on a one-for-one basis. Time-based RSUs typically are scheduled to vest over three or four years. Vesting of time-based RSUs is subject to the grantee’s continued service with Intevac. The compensation expense related to these awards is determined using the fair market value of Intevac common stock on the date of the grant, and the compensation expense is recognized over the vesting period.

Market condition-based RSUs vest upon the achievement of certain market conditions (our stock performance) during a set performance period (typically five years) subject to the grantee’s continued service with Intevac through the date the applicable market condition is achieved. The fair value is based on the values calculated under the Monte Carlo simulation model on the grant date. Compensation cost is not adjusted in future periods for subsequent changes in the expected outcome of market related conditions. The compensation expense is recognized over the derived service period. We granted 125,000 of such awards to certain executive officers in the nine months ended October 1, 2016. These awards have a derived service period of 2.8 years.

Intevac estimated the weighted-average fair value of market condition-based RSUs using the following weighted-average assumptions:

	Nine Months Ended October 1, 2016
Weighted-average fair value of grants per share	$	2.46
Expected volatility		47.65	%
Risk free interest rate		1.35	%
Expected term (in years)		4.79
Dividend yield		None

11

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

In fiscal 2016, the annual bonus for certain participants in the Company’s annual incentive plan was settled with RSUs with one year vesting. The Company accrued for the payment of bonuses at the expected company-wide payout percentage amount at October 1, 2016, which amounts were less than the target bonus amounts for each participant. The bonus accrual was classified as a liability until the number of shares was determined on the date the awards were granted, at which time the Company classified the awards into equity. In February 2017, the annual 2016 bonus for certain participants was settled with RSUs with one-year vesting. 33 participants were granted stock awards to receive an aggregate of 134,000 shares of common stock with a weighted average grant date fair value of $9.63 per share. In February 2016, the annual 2015 bonus for certain participants was settled with RSUs with one year vesting. 34 participants were granted stock awards to receive an aggregate of 266,000 shares of common stock with a weighted average grant date fair value of $4.40 per share. The Company recorded equity-based compensation expense related to the annual incentive plans of $102,000 for the nine months ended September 30, 2017. The Company recorded equity-based compensation expense related to the annual incentive plan of $120,000 and $364,000, respectively, for the three and nine months ended October 1, 2016.

5. Purchased Intangible Assets

Details of finite-lived intangible assets by segment as of September 30, 2017 are as follows.

	September 30, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
Equipment	$	7,172	$	(5,648	)	$	1,524
Photonics		1,215		(1,077	)		138
	$	8,387	$	(6,725	)	$	1,662

Total amortization expense of finite-lived intangibles for the three and nine months ended September 30, 2017 was $169,000 and $596,000, respectively.

As of September 30, 2017, future amortization expense is expected to be as follows.

(In thousands)
2017	$	159
2018		615
2019		615
2020		273
	$	1,662

6. Acquisition-Related Contingent Consideration

In connection with the acquisition of Solar Implant Technologies, Inc. (“SIT”), Intevac agreed to pay to the selling shareholders in cash a revenue earnout on Intevac’s net revenue from commercial sales of certain products over a specified period up to an aggregate of $9.0 million. Intevac estimated the fair value of this contingent consideration on September 30, 2017 based on probability-based forecasted revenues reflecting Intevac’s own assumptions concerning future revenue from such products.

The fair value measurement of contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Any change in fair value of the contingent consideration subsequent to the acquisition date is recognized in income (loss) from operations within the condensed consolidated statement of operations. The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the three and nine month periods ended September 30, 2017 and October 1, 2016:

12

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

	Three Months Ended					Nine Months Ended
	September 30, 2017			October 1, 2016		September 30, 2017			October 1, 2016
	(In thousands)
Opening balance	$	859		$	748	$	759		$	890
Changes in fair value		(283	)		52		(181	)		(90	)
Cash payments made		(172	)		—		(174	)		—
Closing balance	$	404		$	800	$	404		$	800

The following table displays the balance sheet classification of the contingent consideration liability account at September 30, 2017 and at December 31, 2016:

	September 30,		December 31,
	2017		2016
	(In thousands)
Other accrued liabilities	$	36	$	329
Other long-term liabilities		368		430
Total acquisition-related contingent consideration	$	404	$	759

The following table represents the quantitative range of the significant unobservable inputs used in the calculation of fair value of the continent consideration liability as of September 30, 2017. Significant increases or decreases in any of these inputs in isolation would result in a significantly lower or higher fair value measurement.

	Quantitative Information about Level 3 Fair Value Measurements at September 30, 2017
	Fair Value		Valuation Technique	Unobservable Input	Range (Weighted Average)
	(In thousands, except for percentages)
Revenue Earnout	$	404	Discounted cash flow	Weighted average cost of capital Probability weighting of achieving revenue forecasts	11.9% 10.0% - 80.0% (30.0%)

7. Warranty

Intevac provides for the estimated cost of warranty when revenue is recognized. Intevac’s warranty is per contract terms and for its disk manufacturing, solar photovoltaic (“PV”) manufacturing and display cover panel (“DCP”) manufacturing systems the warranty typically ranges between 12 and 24 months from customer acceptance. During this warranty period any defective non-consumable parts are replaced and installed at no charge to the customer. Intevac uses estimated repair or replacement costs along with its historical warranty experience to determine its warranty obligation. Intevac generally provides a twelve month warranty on its Photonics products. The provision for the estimated future costs of warranty is based upon historical cost and product performance experience. Intevac exercises judgment in determining the underlying estimates.

On the condensed consolidated balance sheets, the short-term portion of the warranty provision is included in other accrued liabilities, while the long-term portion is included in other long-term liabilities. The expense associated with product warranties issued or adjusted is included in cost of net revenues on the condensed consolidated statements of operations.

13

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The following table displays the activity in the warranty provision account for the three and nine months ended September 30, 2017 and October 1, 2016:

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
	(In thousands)
Opening balance	$	1,220		$	592		$	1,007		$	982
Expenditures incurred under warranties		(360	)		(80	)		(640	)		(384	)
Accruals for product warranties issued during the reporting period		169			320			675			494
Adjustments to previously existing warranty accruals		106			(110	)		93			(370	)
Closing balance	$	1,135		$	722		$	1,135		$	722

The following table displays the balance sheet classification of the warranty provision account at September 30, 2017 and at December 31, 2016:

	September 30, 2017		December 31, 2016
	(In thousands)
Other accrued liabilities	$	915	$	829
Other long-term liabilities		220		178
Total warranty provision	$	1,135	$	1,007

8. Guarantees

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, Intevac has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at Intevac’s request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The maximum potential amount of future payments Intevac could be required to make under these indemnification obligations is unlimited; however, Intevac has a director and officer insurance policy that mitigates Intevac’s exposure and enables Intevac to recover a portion of any future amounts paid. As a result of Intevac’s insurance policy coverage, Intevac believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in Intevac’s industry, many of Intevac’s contracts provide remedies to certain third parties such as defense, settlement, or payment of judgments for intellectual property claims related to the use of its products. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.

Letters of Credit

As of September 30, 2017, we had letters of credit and bank guarantees outstanding totaling $1.4 million, including a standby letter of credit outstanding under the Santa Clara, California facility lease and various other guarantees with our bank. These letters of credit and bank guarantees are collateralized by $1.4 million of restricted cash.

14

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

9. Cash, Cash Equivalents and Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

	September 30, 2017
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	14,159	$	—	$	—	$	14,159
Money market funds		5,038		—		—		5,038
Total cash and cash equivalents	$	19,197	$	—	$	—	$	19,197
Short-term investments:
Certificates of deposit	$	4,498	$	1	$	1	$	4,498
Commercial paper		1,990		—		—		1,990
Corporate bonds and medium-term notes		6,252		1		5		6,248
Municipal bonds		1,004		—		3		1,001
U.S. treasury and agency securities		4,300		—		—		4,300
Total short-term investments	$	18,044	$	2	$	9	$	18,037
Long-term investments:
Corporate bonds and medium-term notes	$	3,576	$	—	$	3	$	3,573
U.S. treasury and agency securities		2,596		—		4		2,592
Total long-term investments	$	6,172	$	—	$	7	$	6,165
Total cash, cash equivalents, and investments	$	43,413	$	2	$	16	$	43,399
	December 31, 2016
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(in thousands)
Cash and cash equivalents:
Cash	$	18,726	$	—	$	—	$	18,726
Money market funds		8,317		—		—		8,317
Total cash and cash equivalents	$	27,043	$	—	$	—	$	27,043
Short-term investments:
Commercial paper	$	1,992	$	—	$	1	$	1,991
Corporate bonds and medium-term notes		8,586		—		6		8,580
Municipal bonds		600		—		—		600
U.S. treasury and agency securities		6,432		—		1		6,431
Total short-term investments	$	17,610	$	—	$	8	$	17,602
Long-term investments:
Corporate bonds and medium-term notes	$	2,510	$	—	$	11	$	2,499
Municipal bonds		500		—		4		496
U.S. treasury and agency securities		597		1		—		598
Total long-term investments	$	3,607	$	1	$	15	$	3,593
Total cash, cash equivalents, and investments	$	48,260	$	1	$	23	$	48,238

15

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The contractual maturities of available-for-sale securities at September 30, 2017 are presented in the following table.

	Amortized Cost		Fair Value
	(In thousands)
Due in one year or less	$	23,082	$	23,075
Due after one through two years		6,172		6,165
	$	29,254	$	29,240

The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of September 30, 2017.

	September 30, 2017
	In Loss Position for Less than 12 Months				In Loss Position for Greater than 12 Months
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(In thousands)
Certificates of deposit	$	1,249	$	1	$	—	$	—
Corporate bonds and medium-term notes		5,882		7		1,200		1
Municipal bonds		504		1		497		2
U.S. treasury and agency securities		4,118		4		—		—
	$	11,753	$	13	$	1,697	$	3

All prices for the fixed maturity securities including U.S. Treasury and agency securities, certificates of deposit, commercial paper, corporate bonds and municipal bonds are received from independent pricing services utilized by Intevac’s outside investment manager. This investment manager performs a review of the pricing methodologies and inputs utilized by the independent pricing services for each asset type priced by the vendor. In addition, on at least an annual basis, the investment manager conducts due diligence visits and interviews with each pricing vendor to verify the inputs utilized for each asset class. The due diligence visits include a review of the procedures performed by each vendor to ensure that pricing evaluations are representative of the price that would be received for a security in an orderly sale. Any pricing where the input is based solely on a broker price is deemed to be a Level 3 price. Intevac uses the pricing data obtained from its outside investment manager as the primary input to make its assessments and determinations as to the ultimate valuation of the above-mentioned securities and has not made, during the periods presented, any material adjustments to such inputs.

16

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The following table represents the fair value hierarchy of Intevac’s available-for-sale securities measured at fair value on a recurring basis as of September 30, 2017.

	Fair Value Measurements at September 30, 2017
	Total		Level 1		Level 2
	(In thousands)
Recurring fair value measurements:
Available-for-sale securities
Money market funds	$	5,038	$	5,038	$	—
U.S. treasury and agency securities		6,892		4,865		2,027
Certificates of deposit		4,498		—		4,498
Commercial paper		1,990		—		1,990
Corporate bonds and medium-term notes		9,821		—		9,821
Municipal bonds		1,001		—		1,001
Total recurring fair value measurements	$	29,240	$	9,903	$	19,337

10. Derivative Instruments

The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. These derivatives are carried at fair value with changes recorded in interest income and other income (expense), net in the condensed consolidated statements of operations. Changes in the fair value of these derivatives are largely offset by re-measurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. The derivatives have original maturities of approximately 30 days.

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016:

	Notional Amounts				Derivative Liabilities
Derivative Instrument	September 30 2017		December 31, 2016		September 30, 2017					December 31, 2016
					Balance Sheet Line			Fair Value		Balance Sheet Line			Fair Value
	(in thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	1,418	$	1,146		(a	)	$	2		(a	)	$	8
Total Hedges	$	1,418	$	1,146				$	2				$	8

(a) Other accrued liabilities

11. Equity

Stock Repurchase Program

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. At September 30, 2017, $1.5 million remains available for future stock repurchases under the repurchase program. Intevac did not make any stock repurchases during the three and nine months ended September 30, 2017 and October 1, 2016, respectively.

17

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Intevac records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If Intevac reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against retained earnings.

Accumulated Other Comprehensive Income

The changes in accumulated other comprehensive income by component for the three and nine months ended September 30, 2017 and October 1, 2016, are as follows.

	Three Months Ended									Nine Months Ended
	September 30, 2017
	Foreign currency			Unrealized holding losses on available-for-sale investments			Total			Foreign currency		Unrealized holding losses on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	418		$	(19	)	$	399		$	343	$	(22	)	$	321
Other comprehensive income before reclassification		39			5			44			114		8			122
Amounts reclassified from other comprehensive income		—			—			—			—		—			—
Net current-period other comprehensive income		39			5			44			114		8			122
Ending balance	$	457		$	(14	)	$	443		$	457	$	(14	)	$	443
	Three Months Ended									Nine Months Ended
	October 1, 2016
	Foreign currency			Unrealized holding gains on available-for-sale investments			Total			Foreign currency		Unrealized holding gains on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	474		$	17		$	491		$	452	$	(40	)	$	412
Other comprehensive income (loss) before reclassification		(17	)		(16	)		(33	)		5		41			46
Amounts reclassified from other comprehensive income		—			—			—			—		—			—
Net current-period other comprehensive income (loss)		(17	)		(16	)		(33	)		5		41			46
Ending balance	$	457		$	1		$	458		$	457	$	1		$	458

18

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

12. Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share:

	Three Months Ended					Nine Months Ended
	September 30, 2017		October 1, 2016			September 30, 2017		October 1, 2016
	(In thousands, except per share amounts)
Net income (loss)	$	1,230	$	(481	)	$	4,159	$	(10,276	)
Weighted-average shares – basic		21,714		20,869			21,475		20,704
Effect of dilutive potential common shares		1,256		—			1,514		—
Weighted-average shares – diluted		22,970		20,869			22,989		20,704
Net income (loss) per share – basic	$	0.06	$	(0.02	)	$	0.19	$	(0.50	)
Net income (loss) per share –diluted	$	0.05	$	(0.02	)	$	0.18	$	(0.50	)

The following potentially dilutive securities were excluded (as common stock equivalents) from the computation of diluted net income (loss) per share for the periods presented as their effect would have been antidilutive:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Stock options to purchase common stock		826		2,743		834		2,743
RSUs		—		955		—		955
Employee stock purchase plan		—		82		—		82

13. Segment Reporting

Intevac’s two reportable segments are: Thin-film Equipment and Photonics. Intevac’s chief operating decision-maker has been identified as the President and CEO, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Segment information is presented based upon Intevac’s management organization structure as of September 30, 2017 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to the reportable segments disclosed.

Each reportable segment is separately managed and has separate financial results that are reviewed by Intevac’s chief operating decision-maker. Each reportable segment contains closely related products that are unique to the particular segment. Segment operating profit is determined based upon internal performance measures used by the chief operating decision-maker.

Intevac derives the segment results from its internal management reporting system. The accounting policies Intevac uses to derive reportable segment results are substantially the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics, including orders, net revenues and operating income. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. Intevac manages certain operating expenses separately at the corporate level. Intevac allocates certain of these corporate expenses to the segments in an amount equal to 3% of net revenues. Segment operating income excludes interest income/expense and other financial charges and income taxes according to how a particular reportable segment’s management is measured. Management does not consider impairment charges, gains and losses on divestitures and sales of intellectual property, and unallocated costs in measuring the performance of the reportable segments.

19

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The Thin-film Equipment segment designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the hard drive, solar cell and DCP industries, as well as other adjacent thin-film markets.

The Photonics segment develops compact, cost-effective, high-sensitivity digital-optical products for the capture and display of low-light images. Intevac provides sensors, cameras and systems for government applications such as night vision.

Information for each reportable segment for the three and nine months ended September 30, 2017 and October 1, 2016 is as follows:

Net Revenues

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Thin-film Equipment	$	17,177	$	14,272	$	61,087	$	25,941
Photonics		9,549		8,287		26,990		25,201
Total segment net revenues	$	26,726	$	22,559	$	88,077	$	51,142

Operating Income (Loss)

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
	(In thousands)
Thin-film Equipment	$	1,213		$	(998	)	$	4,821		$	(10,117	)
Photonics		1,417			1,737			3,646			3,656
Total segment operating income (loss)		2,630			739			8,467			(6,461	)
Unallocated costs		(1,362	)		(1,063	)		(3,768	)		(3,986	)
Income (loss) from operations		1,268			(324	)		4,699			(10,447	)
Interest income and other income (expense), net		28			60			265			184
Income (loss) before income taxes	$	1,296		$	(264	)	$	4,964		$	(10,263	)

20

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Total assets for each reportable segment as of September 30, 2017 and December 31, 2016 are as follows:

Assets

	September 30, 2017		December 31, 2016
	(In thousands)
Thin-film Equipment	$	52,620	$	39,503
Photonics		16,563		16,071
Total segment assets		69,183		55,574
Cash, cash equivalents and investments		43,399		48,238
Restricted cash		1,400		1,602
Deferred income taxes		4		3
Other current assets		1,024		997
Common property, plant and equipment		1,698		1,039
Other assets		724		871
Consolidated total assets	$	117,432	$	108,324

14. Income Taxes

Intevac recorded income tax provisions of $66,000 and $805,000 for the three and nine months ended September 30, 2017, respectively, and $217,000 and $13,000 for the three and nine months ended October 1, 2016, respectively. The income tax provision for the nine months ended September 30, 2017 includes $506,000 for withholding taxes on royalties payable to the United States from Intevac’s Singapore subsidiary and $200,000 for audit considerations in foreign jurisdictions, both recorded as discrete items. The income tax provisions for the three and nine month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. Intevac did not recognize benefits on the U.S. net operating loss for the three and nine month period ended September 30, 2017 due to having full valuation allowances on the U.S. deferred tax assets. Intevac did not recognize benefits on the U.S. net operating loss or on the Singapore net operating loss for the three and nine month period ended October 1, 2016 due to having full valuation allowances on the U.S. deferred tax assets and on the Singapore deferred tax assets. Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, the utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

The Inland Revenue Authority of Singapore (“IRAS”) is currently conducting a review of the fiscal 2009 through 2012 tax returns of the Company’s wholly-owned subsidiary, Intevac Asia Pte. Ltd. IRAS has challenged the Company’s tax position with respect to certain aspects of the Company’s transfer pricing. Under Singapore tax law, the Company must pay all contested taxes and the related interest to have the right to defend its position. The contested tax deposits of $724,000 at September 30, 2017 and $871,000 at December 31, 2016 are included in other long-term assets on the condensed consolidated balance sheets. The Company’s management and its advisors continue to believe that the Company is “more likely than not” to successfully defend that the tax treatment was proper and in accordance with Singapore tax regulations. Presently, there are no other active income tax examinations in the jurisdictions where Intevac operates.

15. Contingencies

From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.

21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q contains forward-looking statements, which involve risks and uncertainties. Words such as “believes,” “expects,” “anticipates” and the like indicate forward-looking statements. These forward-looking statements include comments related to Intevac’s shipments, projected revenue recognition, product costs, gross margin, operating expenses, interest income, income taxes, cash balances and financial results in 2017 and beyond; projected customer requirements for Intevac’s new and existing products, and when, and if, Intevac’s customers will place orders for these products; Intevac’s ability to proliferate its Photonics technology into major military programs and to develop and introduce commercial imaging products; the timing of delivery and/or acceptance of the systems and products that comprise Intevac’s backlog for revenue and the Company’s ability to achieve cost savings. Intevac’s actual results may differ materially from the results discussed in the forward-looking statements for a variety of reasons, including those set forth under “Risk Factors” and in other documents we file from time to time with the Securities and Exchange Commission, including our Annual Report on Form 10-K filed on February 15, 2017, and our periodic Form 10-Q’s and Form 8-K’s.

Overview

Intevac is a provider of vacuum deposition equipment for a wide variety of thin-film applications, and a leading provider of digital night-vision technologies and products to the defense industry. The Company leverages its core capabilities in high-volume manufacturing of small substrates to provide process manufacturing equipment solutions to the hard disk drive (“HDD”), display cover panel (“DCP”), and solar cell industries. Intevac also provides sensors, cameras and systems for government applications such as night vision. Intevac’s customers include manufacturers of hard disk media, DCPs and solar cells as well as the U.S. government and its agencies, allies and contractors. Intevac reports two segments: Thin-film Equipment and Photonics.

Product development and manufacturing activities occur in North America and Asia. Intevac has field offices in Asia to support its Thin-film Equipment customers. Intevac’s products are highly technical and are sold primarily through Intevac’s direct sales force. Intevac also sells its products through distributors in Japan and China.

Intevac’s results are driven by a number of factors including success in its equipment growth initiatives in the DCP and solar markets and by worldwide demand for HDDs. Demand for HDDs depends on the growth in digital data creation and storage, the rate of areal density improvements, the end-user demand for PCs, enterprise data storage, nearline “cloud” applications, video players and video game consoles that include such drives. Intevac continues to execute its strategy of equipment diversification into new markets by introducing new products, such as for a thin-film physical vapor deposition (“PVD”) application for protective coating for DCP manufacturing and a thin-film PVD application for PV solar cell manufacturing. Intevac believes that expansion into these markets will result in incremental equipment revenues for Intevac and decrease Intevac’s dependence on the HDD industry. Intevac’s equipment business is subject to cyclical industry conditions, as demand for manufacturing equipment and services can change depending on supply and demand for HDDs, cell phones, and PV cells as well as other factors such as global economic conditions and technological advances in fabrication processes.

22

The following table presents certain significant measurements for the three and nine months ended September 30, 2017 and October 1, 2016:

	Three months ended								Nine months ended
	September 30, 2017			October 1, 2016			Change over prior period		September 30, 2017			October 1, 2016			Change over prior period
	(In thousands, except percentages and per share amounts)
Net revenues	$	26,726		$	22,559		$	4,167	$	88,077		$	51,142		$	36,935
Gross profit	$	11,298		$	8,515		$	2,783	$	35,816		$	18,497		$	17,319
Gross margin percent		42.3	%		37.7	%		4.6 points		40.7	%		36.2	%		4.5 points
Income (loss) from operations	$	1,268		$	(324	)	$	1,592	$	4,699		$	(10,447	)	$	15,146
Net income (loss)	$	1,230		$	(481	)	$	1,711	$	4,159		$	(10,276	)	$	14,435
Net income (loss) per diluted share	$	0.05		$	(0.02	)	$	0.07	$	0.18		$	(0.50	)	$	0.68

Net revenues for the third quarter of fiscal 2017 increased compared to the same period in the prior year primarily due to higher technology upgrade and spare parts sales to HDD manufacturers and to higher Photonics product sales and higher Photonics contract research and development (“R&D”). Thin-film Equipment recognized revenue on two 200 Lean^® HDD systems in both the third quarter of fiscal 2017 and third quarter of fiscal 2016. Thin-film Equipment also recognized revenue on one pilot ENERGi™ solar ion implant system in the third quarter of fiscal 2016. Net income for the third quarter of fiscal 2017 increased compared to the same period in the prior year due to higher revenues and higher gross profit offset in part by higher spending on research and development and higher selling, general and administrative expenses as the Company recorded higher variable compensation expenses as a result of the return to profitability.

Net revenues for the first nine months of fiscal 2017 increased compared to the same period in the prior year primarily due to higher equipment sales to HDD, PV and cell phone manufacturers, higher Photonics contract R&D and by higher Photonics product sales. Thin-film Equipment recognized revenue in the first nine months of fiscal 2017 on four 200 Lean HDD systems, one pilot INTEVAC MATRIX™ solar ion implant system, two ENERGi solar ion implant systems and four INTEVAC VERTEX™ coating systems for DCP. Thin-film Equipment recognized revenue in the first nine months of fiscal 2016 on two 200 Lean HDD systems, one pilot ENERGi solar ion implant system and one VERTEX system. The net income for the first nine months of fiscal 2017 increased compared to the same period in the prior year due to higher revenues, higher gross profit, and lower spending on research and development offset in part by higher selling, general and administrative expenses as the Company recorded higher variable compensation expenses as a result of the return to profitability and higher legal fees related to patents and contracts.

Given the momentum we have built in our business, we believe that we are currently on the path to profitability in fiscal 2017. Intevac expects higher sales of new Thin-film Equipment products for DCP and PV and higher sales of HDD equipment. For fiscal 2017, Intevac expects that Photonics business levels will be at about the same levels as 2016 as Photonics continues to deliver production shipments of the pilot night-vision systems for the Apache helicopter and night-vision camera modules for the F35 Joint Strike Fighter program. Deliveries under the current multi-year Apache arrangement are expected to be completed in the fourth quarter of 2017.

Intevac’s trademarks, include the following: “200 Lean^®,” “AccuLuber™,” “EBAPS^®,” “ENERGi™,” “I-Port™,” “LIVAR^®,” “INTEVAC LSMA™,” “INTEVAC MATRIX™,” “MicroVista^®,” “NightVista^®,” “Night Port™,” “oDLC™” and “INTEVAC VERTEX™”.

23

Results of Operations

Net revenues

	Three months ended						Nine months ended
	September 30, 2017		October 1, 2016		Change over prior period		September 30, 2017		October 1, 2016		Change over prior period
	(In thousands)
Thin-film Equipment	$	17,177	$	14,272	$	2,905	$	61,087	$	25,941	$	35,146
Photonics:
Products	$	7,360	$	6,689	$	671	$	21,735	$	21,385	$	350
Contract R&D		2,189		1,598		591		5,255		3,816		1,439
		9,549		8,287		1,262		26,990		25,201		1,789
Total net revenues	$	26,726	$	22,559	$	4,167	$	88,077	$	51,142	$	36,935

Thin-film Equipment revenue for the three months ended September 30, 2017 increased over the same period in the prior year as a result of higher sales of technology upgrades and spare parts. Thin-film Equipment revenue for the three months ended September 30, 2017 included revenue recognized for two 200 Lean HDD systems. Thin-film Equipment revenue for the three months ended October 1, 2016 included two 200 Lean systems and a pilot ENERGi solar ion implant tool. Thin-film Equipment revenue for the nine months ended September 30, 2017 increased over the same period in the prior year as a result of higher sales of systems, technology upgrades, service and spare parts. Thin-film Equipment recognized revenue in the first nine months of fiscal 2017 on four 200 Lean HDD systems, one pilot MATRIX solar ion implant system, two ENERGi solar ion implant systems and four VERTEX coating systems for DCP. Thin-film Equipment recognized revenue in the first nine months of fiscal 2016 on two 200 Lean HDD systems, one pilot ENERGi solar ion implant system and one VERTEX system.

Photonics revenue for the three and nine month periods ended September 30, 2017 increased from the same periods in the prior year as a result of higher product sales revenues and by increased contract R&D work.

Backlog

	September 30, 2017		December 31, 2016		October 1, 2016
	(In thousands)
Thin-film Equipment	$	59,375	$	46,283	$	49,234
Photonics		13,457		22,244		23,703
Total backlog	$	72,832	$	68,527	$	72,937

Thin-film Equipment backlog at September 30, 2017 included five 200 Lean HDD systems and twelve ENERGi solar ion implant systems. Thin-film Equipment backlog at December 31, 2016 included four 200 Lean HDD systems, four VERTEX systems for DCP, one pilot MATRIX solar ion implant system, and two ENERGi solar ion implant systems. Thin-film Equipment backlog at October 1, 2016 included four 200 Lean HDD systems, one MATRIX solar PVD system, three VERTEX systems for DCP, one pilot MATRIX solar ion implant system, and two ENERGi solar ion implant systems.

24

Revenue by geographic region

	Three months ended							Nine months ended
	September 30, 2017		October 1, 2016		Change over prior period			September 30, 2017		October 1, 2016		Change over prior period
	(In thousands)
United States	$	10,294	$	9,066	$	1,228		$	29,879	$	27,603	$	2,276
Asia		15,807		13,311		2,496			57,062		22,801		34,261
Europe		94		182		(88	)		605		738		(133	)
Rest of World		531		—		531			531		—		531
Total net revenues	$	26,726	$	22,559	$	4,167		$	88,077	$	51,142	$	36,935

International sales include products shipped to overseas operations of U.S. companies. The increase in sales to the U.S. region in 2017 versus 2016 reflected higher Photonics contract R&D work and higher Photonics product sales. The increase in sales to the Asia region in 2017 versus 2016 reflected higher system sales. Sales to the Asia region in 2017 included four 200 Lean HDD systems, four VERTEX coating systems for DCP, one pilot MATRIX solar ion implant system and two ENERGi solar ion implant systems versus two 200 Lean HDD systems, one pilot ENERGi solar ion implant tool one and VERTEX coating system in 2016. Sales to the Europe region in 2017 and 2016 were not significant. Rest of World includes contract R&D for the Australian government as part of a program under the Department of Defense’s Coalition Warfare Program, which is funded by the U.S. government and several foreign nation coalition partners.

Gross profit

	Three months ended									Nine months ended
	September 30, 2017			October 1, 2016			Change over prior period			September 30, 2017			October 1, 2016			Change over prior period
	(In thousands, except percentages)
Thin-film Equipment gross profit	$	7,812		$	4,628		$	3,184		$	25,686		$	7,337		$	18,349
% of Thin-film Equipment net revenues		45.5	%		32.4	%					42.0	%		28.3	%
Photonics gross profit	$	3,486		$	3,887		$	(401	)	$	10,130		$	11,160		$	(1,030	)
% of Photonics net revenues		36.5	%		46.9	%					37.5	%		44.3	%
Total gross profit	$	11,298		$	8,515		$	2,783		$	35,816		$	18,497		$	17,319
% of net revenues		42.3	%		37.7	%					40.7	%		36.2	%

Cost of net revenues consists primarily of purchased materials and costs attributable to contract research and development, and also includes fabrication, assembly, test and installation labor and overhead, customer-specific engineering costs, warranty costs, royalties, provisions for inventory reserves and scrap.

Thin-film Equipment gross margin was 45.5% in the three months ended September 30, 2017 compared to 32.4% in the three months ended October 1, 2016 and was 42.0% in the nine months ended September 30, 2017 compared to 28.3% in the nine months ended October 1, 2016. The improvement in gross margin for the three and nine months ended September 30, 2017 was due primarily to higher revenue, increased shipments of higher-margin upgrades and higher factory utilization. Thin-film Equipment gross margin for the nine months ended September 30, 2017 reflects the release of $2.2 million on previously-recognized inventory provisions upon the sale of two ENERGi solar ion implant systems, offset in part by the lower margin on the pilot MATRIX solar ion implant system. Gross margin for the three and nine months ended October 1, 2016 reflected the lower margin on a pilot ENERGi solar implant tool sold to an R&D facility. Gross margins in the Thin-film Equipment business will vary depending on a number of factors, including product mix, product cost, system configuration and pricing, factory utilization, and provisions for excess and obsolete inventory.

25

Photonics gross margin was 36.5% in the three months ended September 30, 2017 compared to 46.9% in the three months ended October 1, 2016 and was 37.5% in the nine months ended September 30, 2017 compared to 44.3% in the nine months ended October 1, 2016. The decline in gross margin for the three months ended September 30, 2017 was due to lower margins on contract R&D, higher inventory provisions and higher manufacturing engineering spending. The lower gross margin for the nine months ended September 30, 2017 was due to loss provisions recorded on firm fixed price contracts, higher inventory provisions and higher manufacturing engineering spending. Gross margins in the Photonics business will vary depending on a number of factors, including sensor yield, product mix, product cost, pricing, factory utilization, provisions for warranty and inventory reserves.

Research and development

	Three months ended						Nine months ended
	September 30, 2017		October 1, 2016		Change over prior period		September 30, 2017		October 1, 2016		Change over prior period
	(In thousands)
Research and development expense	$	4,535	$	4,067	$	468	$	13,635	$	14,220	$	(585	)

Research and development spending in Thin-film Equipment during the three and nine months ended September 30, 2017 increased compared to the same periods in the prior year. Thin-film Equipment spending consisted primarily of PV and DCP development. Research and development spending decreased in Photonics during the three and nine months ended September 30, 2017 as compared to the same periods in the prior year. Photonics spending during the three and nine months ended October 1, 2016 reflected incremental spending on demonstrators developed for evaluation by the U.S. Army and U.S. Navy which were self-funded by Intevac. Research and development expenses do not include costs of $2.0 million and $4.8 million for the three and nine months ended September 30, 2017 respectively, or $1.0 million and $3.2 million for the three and nine months ended October 1, 2016 respectively, which are related to customer-funded contract R&D programs at Photonics and therefore included in cost of net revenues.

Selling, general and administrative

	Three months ended						Nine months ended
	September 30, 2017		October 1, 2016		Change over prior period		September 30, 2017		October 1, 2016		Change over prior period
	(In thousands)
Selling, general and administrative expense	$	5,495	$	4,772	$	723	$	17,482	$	14,724	$	2,758

Selling, general and administrative expense consists primarily of selling, marketing, customer support, financial and management costs. Selling, general and administrative expenses for the three and nine months ended September 30, 2017 increased compared to the same periods in the prior year primarily due to higher variable compensation costs as a result of the Company’s return to profitability, increased legal expenses for patent applications and increased spending for strategic consulting. Selling, general and administrative expense for the three months ended September 30, 2017 is net of a benefit of $283,000 compared to a charge of $52,000 for the three months ended October 1, 2016 associated with changes in the fair value of the contingent consideration related to a revenue earnout obligation. Selling, general and administrative expense for the nine months ended September 30, 2017 is net of a benefit of $181,000 compared to a benefit of $90,000 for the nine months ended October 1, 2016 associated with changes in the fair value of the contingent consideration related to the revenue earnout obligation.

26

Interest income and other income (expense), net

	Three months ended							Nine months ended
	September 30, 2017		October 1, 2016		Change over prior period			September 30, 2017		October 1, 2016		Change over prior period
	(In thousands)
Interest income and other income (expense), net	$	28	$	60	$	(32	)	$	265	$	184	$	81

Interest income and other income (expense), net is comprised of interest income, foreign currency gains and losses, and other income and expense such as gains and losses on sales of fixed assets and earnout income from divestitures.

Provision for income taxes

	Three months ended							Nine months ended
	September 30, 2017		October 1, 2016		Change over prior period			September 30, 2017		October 1, 2016		Change over prior period
	(In thousands)
Provision for income taxes	$	66	$	217	$	(151	)	$	805	$	13	$	792

Intevac recorded income tax provisions of $66,000 and $805,000 for the three and nine months ended September 30, 2017, respectively, and $217,000 and $13,000 for the three and nine months ended October 1, 2016, respectively. The income tax provision for the nine months ended September 30, 2017 includes $506,000 for withholding taxes on royalties payable to the United States from Intevac’s Singapore subsidiary and $200,000 for audit considerations in foreign jurisdictions, both recorded as discrete items. The income tax provisions for the three and nine month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. Intevac did not recognize benefits on the U.S. net operating loss for the three and nine month period ended September 30, 2017 due to having full valuation allowances on the U.S. deferred tax assets. Intevac did not recognize benefits on the U.S. net operating loss or on the Singapore net operating loss for the three and nine month period ended October 1, 2016 due to having full valuation allowances on the U.S. deferred tax assets and on the Singapore deferred tax assets. Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, the utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

Liquidity and Capital Resources

At September 30, 2017, Intevac had $43.4 million in cash, cash equivalents, and investments compared to $48.2 million at December 31, 2016. During the first nine months of 2017, cash, cash equivalents and investments decreased by $4.8 million due primarily to cash used by operating activities, purchases of fixed assets and tax payments related to the net share settlement of restricted stock units, partially offset by cash received from the sale of Intevac common stock to Intevac’s employees through Intevac’s employee benefit plans.

27

Cash, cash equivalents and investments consist of the following:

	September 30, 2017		December 31, 2016
	(In thousands)
Cash and cash equivalents	$	19,197	$	27,043
Short-term investments		18,037		17,602
Long-term investments		6,165		3,593
Total cash, cash equivalents and investments	$	43,399	$	48,238

Operating activities used cash of $1.7 million during the first nine months of 2017 and used cash of $3.1 million during the first nine months of 2016. The improvement in operating cash flows was due primarily to higher net income as a result of the return to profitability, offset in part by additional investments in working capital during the first nine months of 2017.

Accounts receivable totaled $22.3 million at September 30, 2017 compared to $17.4 million at December 31, 2016 primarily as a result of billings for third quarter revenue and customer advances. At September 30, 2017, customer advances for products that had not been shipped to customers and included in accounts receivable were $4.0 million. Net inventories totaled $32.6 million at September 30, 2017 compared to $24.9 million at December 31, 2016. The increase was due primarily to three Energi systems that were undergoing installation and acceptance testing and included in finished goods at September 30, 2017 and higher levels of production inventories for planned 2017 and 2018 shipments, offset in part by recognition of previously deferred revenue on four VERTEX systems and two Energi systems that were undergoing installation and acceptance testing and included in finished goods at December 31, 2016. Accounts payable totaled $7.0 million at September 30, 2017 compared to $5.3 million at December 31, 2016. The increase was due primarily to increased materials purchases to support planned shipments. Accrued payroll and related liabilities increased to $5.8 million at September 30, 2017 compared to $4.2 million at December 31, 2016 due primarily to higher accruals for 2017 bonuses and profit sharing due to the return to profitability, offset in part by the settlement of 2016 bonuses. Other accrued liabilities decreased to $7.9 million at September 30, 2017 compared to $17.0 million at December 31, 2016 due primarily to the recognition of previously deferred revenue. Customer advances increased from $5.4 million at December 31, 2016 to $12.3 million at September 30, 2017, primarily due to the receipt of new customer orders.

Investing activities used cash of $6.4 million during the first nine months of 2017. Purchases of investments net of proceeds from sales totaled $3.1 million. Capital expenditures for the nine months ended September 30, 2017 were $3.6 million.

Financing activities generated cash of $182,000 in the first nine months of 2017. The sale of Intevac common stock to Intevac’s employees through Intevac’s employee benefit plans generated cash of $2.3 million. Tax payments related to the net share settlement of restricted stock units were $2.0 million.

Intevac’s investment portfolio consists principally of investment grade money market mutual funds, U.S. Treasury and agency securities, certificates of deposit, commercial paper, municipal bonds and corporate bonds. Intevac regularly monitors the credit risk in its investment portfolio and takes measures, which may include the sale of certain securities, to manage such risks in accordance with its investment policies.

As of September 30, 2017, approximately $10.9 million of cash and cash equivalents and $3.3 million of short-term investments were domiciled in foreign tax jurisdictions. Intevac expects a significant portion of these funds to remain offshore in the short term. If the Company chose to repatriate these funds to the United States, it would be required to accrue and pay additional taxes on any portion of the repatriation where no United States income tax had been previously provided.

Intevac believes that its existing cash, cash equivalents and investments will be sufficient to meet its cash requirements for the foreseeable future. Intevac intends to undertake approximately $2.0 million to $3.0 million in capital expenditures during the remainder of 2017.

28

Off-Balance Sheet Arrangements

Off-balance sheet firm commitments relating to outstanding letters of credit amounted to approximately $1.4 million as of September 30, 2017. These letters of credit and bank guarantees are collateralized by $1.4 million of restricted cash. We do not maintain any other off-balance sheet arrangements, transactions, obligations, or other relationships that would be expected to have a material current or future effect on the consolidated financial statements.

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported. Intevac’s significant accounting policies are described in Note 1 to the consolidated financial statements included in Item 8 of Intevac’s Annual Report on Form 10-K filed on February 15, 2017. Certain of these significant accounting policies are considered to be critical accounting policies, as defined below.

A critical accounting policy is defined as one that is both material to the presentation of Intevac’s financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on Intevac’s financial conditions and results of operations. Specifically, critical accounting estimates have the following attributes: 1) Intevac is required to make assumptions about matters that are highly uncertain at the time of the estimate; and 2) different estimates Intevac could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on Intevac’s financial condition or results of operations.

Estimates and assumptions about future events and their effects cannot be determined with certainty. Intevac bases its estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as Intevac’s operating environment changes. These changes have historically been minor and have been included in the consolidated financial statements as soon as they become known. In addition, management is periodically faced with uncertainties, the outcomes of which are not within its control and will not be known for prolonged periods of time. Many of these uncertainties are discussed in the section below entitled “Risk Factors.” Based on a critical assessment of Intevac’s accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that Intevac’s consolidated financial statements are fairly stated in accordance with US GAAP, and provide a meaningful presentation of Intevac’s financial condition and results of operation.

For further information about Intevac’s other critical accounting policies, see the discussion of critical accounting policies in Intevac’s 2016 Form 10-K. Beginning January 1, 2017, Intevac accounts for forfeitures on stock-based compensation as they occur, rather than estimate expected forfeitures. Except for the change in accounting policy for the timing of recognition of forfeitures, management believes that there have been no significant changes during the nine months ended September 30, 2017 to the items identified as critical accounting policies in Intevac’s 2016 Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest rate risk. Intevac’s exposure to market risk for changes in interest rates relates primarily to its investment portfolio. Intevac does not use derivative financial instruments in Intevac’s investment portfolio. The Company has adopted an investment policy and established guidelines relating to credit quality, diversification and maturities of its investments in order to preserve principal and maintain liquidity. All investment securities in Intevac’s portfolio have an investment grade credit rating. Investments typically consist of certificates of deposit, commercial paper, obligations of the U.S. government and its agencies, corporate debt securities and municipal bonds.

29

The table below presents principal amounts and related weighted-average interest rates by year of expected maturity for Intevac’s investment portfolio at September 30, 2017.

	2017			2018			2019			Total		Fair Value
	(In thousands, except percentages)
Cash equivalents Variable rate amounts	$	5,038		$	—		$	—		$	5,038	$	5,038
Weighted-average rate		0.93	%		—			—
Short-term investments Fixed rate amounts	$	6,247		$	11,797		$	—		$	18,044	$	18,037
Weighted-average rate		1.49	%		1.37	%		—
Long-term investments Fixed rate amounts	$	—		$	598		$	5,574		$	6,172	$	6,165
Weighted-average rate		—			1.00	%		1.87	%
Total investment portfolio	$	11,285		$	12,395		$	5,574		$	29,254	$	29,240

Foreign exchange risk. From time to time, Intevac enters into foreign currency forward exchange contracts to hedge certain of its anticipated foreign currency re-measurement exposures and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. The objective of these contracts is to minimize the impact of foreign currency exchange rate movements on Intevac’s operating results. The derivatives have original maturities of approximately 30 days. The notional amount of Company’s foreign currency derivatives was $1.4 million at September 30, 2017 and $1.1 million at December 31, 2016.

Item 4. Controls and Procedures

Evaluation of disclosure controls and procedures

Intevac maintains a set of disclosure controls and procedures that are designed to ensure that information relating to Intevac required to be disclosed in periodic filings under the Securities Exchange Act of 1934, or Exchange Act, is recorded, processed, summarized and reported in a timely manner under the Exchange Act. In connection with the filing of this Form 10-Q for the quarter ended September 30, 2017, as required under Rule 13a-15(b) of the Exchange Act, an evaluation was carried out under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer (the “CEO” and “CFO”), of the effectiveness of Intevac’s disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, Intevac’s Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of September 30, 2017.

Attached as exhibits to this Quarterly Report are certifications of the CEO and the CFO, which are required in accordance with Rule 13a-14 of the Exchange Act. This Controls and Procedures section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Definition of disclosure controls

Disclosure Controls are controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure Controls are also designed to ensure that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Our Disclosure Controls include components of our internal control over financial reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the U.S. To the extent that components of our internal control over financial reporting are included within our Disclosure Controls, they are included in the scope of our quarterly controls evaluation.

30

Limitations on the effectiveness of controls

Intevac’s management, including the CEO and CFO, does not expect that Intevac’s Disclosure Controls or Intevac’s internal control over financial reporting will prevent all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Intevac have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in internal controls over financial reporting

There were no changes in our internal controls over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, Intevac’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, Intevac is involved in claims and legal proceedings that arise in the ordinary course of business. Intevac expects that the number and significance of these matters will increase as Intevac’s business expands. Any claims or proceedings against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time, result in the diversion of significant operational resources, or require us to enter into royalty or licensing agreements which, if required, may not be available on terms favorable to us or at all. Intevac is not presently a party to any lawsuit or proceeding that, in Intevac’s opinion, is likely to seriously harm Intevac’s business.

Item 1A. Risk Factors

The following factors could materially affect Intevac’s business, financial condition or results of operations and should be carefully considered in evaluating the Company and its business, in addition to other information presented elsewhere in this report.

The industries we serve are cyclical, volatile and unpredictable.

A significant portion of our revenue is derived from the sale of equipment used to manufacture commodity technology products such as disk drives, PV solar cells and cell phones. This subjects us to business cycles, the timing, length and volatility of which can be difficult to predict. When demand for commodity technology products exceeds production capacity, then demand for new capital equipment such as ours tends to be amplified. Conversely, when supply of commodity technology products exceeds demand, then demand for new capital equipment such as ours tends to be depressed. For example, sales of systems for magnetic disk production were depressed from late 2007 through 2009. The number of new systems delivered increased in 2010 as customers increased their production capacity in response to increased demand for data storage, but decreased in 2011 through 2015 as the hard disk drive industry did not add the same level of capacity that it did in 2010. We cannot predict with any certainty when these cycles will begin or end. Our sales of systems for magnetic disk production increased modestly in 2016 as a customer upgraded the technology level of its manufacturing capacity. 2017 sales of systems for magnetic disk production to date have been higher than 2016 levels, and we anticipate the trend will continue for the remainder of 2017.

31

Our equipment represents only a portion of the capital expenditure that our customers incur when they upgrade or add production capacity. Accordingly, our customers generally commit to making large capital expenditures far in excess of the cost of our systems alone when they decide to purchase our systems. The magnitude of these capital expenditures requires our customers to have access to large amounts of capital. Our customers generally reduce their level of capital investment during downturns in the overall economy or during a downturn in their industries.

In recent years the photovoltaic (solar) market has undergone a downturn, which is likely to impact our sales of PV equipment. The solar industry from time to time experiences periods of structural imbalance between supply and demand. And such periods put intense pressure on our customers’ pricing. The solar industry is currently in such a period. Competition in solar markets globally and across the solar value chain is intense, and could remain that way for an extended period of time. During any such period, solar module manufacturers may reduce their sales prices in response to competition, even below their manufacturing costs, in order to generate sales and may do so for a sustained period of time. As a result, our customers may be unable to sell their solar modules or systems at attractive prices or for a profit during a period of excess supply of solar modules, which would adversely affect their results of operations and their ability to make capital investments such as purchasing our products.

We must effectively manage our resources and production capacity to meet rapidly changing demand. Our business experiences rapid growth and contraction, which stresses our infrastructure, internal systems and managerial resources. During periods of increasing demand for our products, we must have sufficient manufacturing capacity and inventory to meet customer demand; attract, retain and motivate a sufficient number of qualified individuals; and effectively manage our supply chain. During periods of decreasing demand for our products, we must be able to align our cost structure with prevailing market conditions; motivate and retain key employees and effectively manage our supply chain.

Sales of our equipment are primarily dependent on our customers’ upgrade and capacity expansion plans and whether our customers select our equipment.

We have no control over our customers’ upgrade and capacity expansion plans, and we cannot be sure they will select, or continue to select, our equipment when they upgrade or expand their capacity. The sales cycle for our equipment systems can be a year or longer, involving individuals from many different areas of Intevac and numerous product presentations and demonstrations for our prospective customers. Our sales process also commonly includes production of samples and customization of our products. We do not typically enter into long-term contracts with our customers, and until an order is actually submitted by a customer there is no binding commitment to purchase our systems.

Sales of new manufacturing systems are also dependent on obsolescence and replacement of the installed base of our customers’ existing equipment with newer, more capable equipment. If upgrades are developed that extend the useful life of the installed base of systems, then we tend to sell more upgrade products and fewer new systems, which can significantly reduce total revenue. For example, some of our 200 Lean customers continue to use legacy systems for the production of perpendicular media, which delayed the replacement of such systems with new 200 Lean systems.

Our 200 Lean customers also experience competition from companies that produce alternative storage technologies like flash memory, which offer smaller size, lower power consumption and more rugged designs. These storage technologies are being used increasingly in enterprise applications and smaller form factors such as tablets, smart-phones, ultra-books, and notebook PCs instead of hard disk drives. Tablet computing devices and smart-phones have never contained, nor are they likely in the future to contain, a disk drive. Products using alternative technologies, such as flash memory, optical storage and other storage technologies are becoming increasingly common and could become a significant source of competition to particular applications of the products of our 200 Lean customers, which could adversely affect our results of operations. If alternative technologies, such as flash memory, replace hard disk drives as a significant method of digital storage, then demand for our hard disk manufacturing products would decrease.

32

The Photonics business is also subject to long sales cycles because many of its products, such as our military imaging products, often must be designed into the customers’ end products, which are often complex state-of-the-art products. These development cycles are typically multi-year, and our sales are contingent on our customers successfully integrating our product into their product, completing development of their product and then obtaining production orders for their product from the U.S. government or its allies.

We operate in an intensely competitive marketplace, and our competitors have greater resources than we do.

In the market for our disk sputtering systems, we experience competition primarily from Canon Anelva, which has sold a substantial number of systems worldwide. In the PV equipment market, Intevac faces competition from large established competitors including Applied Materials, Centrotherm Photovoltaics, Amtech, Jusung and Von Ardenne. In the market for our military imaging products we experience competition from companies such as Harris Corporation and L-3 Communications. Some of our competitors have substantially greater financial, technical, marketing, manufacturing and other resources than we do, especially in the DCP and PV equipment markets. Our competitors may develop enhancements to, or future generations of, competitive products that offer superior price or performance features, and new competitors may enter our markets and develop such enhanced products. Moreover, competition for our customers is intense, and our competitors have historically offered substantial pricing concessions and incentives to attract our customers or retain their existing customers.

Our growth depends on development of technically advanced new products and processes.

We have invested heavily, and continue to invest, in the development of new products, such as our 200 Lean and other PVD systems, our coating systems for DCP, our solar systems for PV applications, our digital night-vision products and our near-eye display products. Our success in developing and selling new products depends upon a variety of factors, including our ability to: predict future customer requirements; make technological advances; achieve a low total cost of ownership for our products; introduce new products on schedule; manufacture products cost-effectively including transitioning production to volume manufacturing; commercialize and attain customer acceptance of our products; and achieve acceptable and reliable performance of our new products in the field. Our new product decisions and development commitments must anticipate continuously evolving industry requirements significantly in advance of sales. In addition, we are attempting to expand into new or related markets, including the PV and cell phone cover glass markets. Our expansion into the PV market is dependent upon the success of our customers’ development plans. To date we have not recognized material revenue from such products. Failure to correctly assess the size of the markets, to successfully develop cost effective products to address the markets or to establish effective sales and support of the new products would have a material adverse effect on future revenues and profits. In addition, if we invest in products for which the market does not develop as anticipated, we may incur significant charges related to such investments.

Rapid technological change in our served markets requires us to rapidly develop new technically advanced products. Our future success depends in part on our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products have reliability or quality problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance and payment for new products and additional service and warranty expenses.

We are exposed to risks associated with a highly concentrated customer base.

Historically, a significant portion of our revenue in any particular period has been attributable to sales of our disk sputtering systems to a limited number of customers. This concentration of customers, when combined with changes in the customers’ specific capacity plans and market share shifts, can lead to extreme variability in our revenue and financial results from period to period.

The concentration of our customer base may enable our customers to demand pricing and other terms unfavorable to Intevac, and makes us more vulnerable to changes in demand by a given customer. Orders from a relatively limited number of manufacturers have accounted for, and will likely continue to account for, a substantial portion of our revenues. The loss of one of these large customers, or delays in purchasing by them, could have a material and adverse effect on our revenues.

33

Our operating results fluctuate significantly from quarter to quarter, which can lead to volatility in the price of our common stock.

Our quarterly revenues and common stock price have fluctuated significantly. We anticipate that our revenues, operating margins and common stock price will continue to fluctuate for a variety of reasons, including: (1) changes in the demand, due to seasonality, cyclicality and other factors in the markets for computer systems, storage subsystems and consumer electronics containing disks as well as cell phones and PV solar cells our customers produce with our systems; (2) delays or problems in the introduction and acceptance of our new products, or delivery of existing products; (3) timing of orders, acceptance of new systems by our customers or cancellation of those orders; (4) new products, services or technological innovations by our competitors or us; (5) changes in our manufacturing costs and operating expense; (6) changes in general economic, political, stock market and industry conditions; and (7) any failure of our operating results to meet the expectations of investment research analysts or investors.

Any of these, or other factors, could lead to volatility and/or a rapid change in the trading price of our common shares. In the past, securities class action litigation has been instituted against companies following periods of volatility in the market price of their securities. Any such litigation, if instituted against Intevac, could result in substantial costs and diversion of management time and attention.

We may not be able to obtain export licenses from the U.S. government permitting delivery of our products to international customers.

Many of our products, especially Photonics products, require export licenses from U.S. government agencies under the Export Administration Act, the Trading with the Enemy Act of 1917, the Arms Export Act of 1976 or the International Traffic in Arms Regulations. These regulations limit the potential market for some of our products. We can give no assurance that we will be successful in obtaining all the licenses necessary to export our products. Heightened government scrutiny of export licenses for defense related products has resulted in lengthened review periods for our license applications. Exports to countries that are not considered by the U.S. government to be allies are likely to be prohibited, and even sales to U.S. allies may be limited. Failure to comply with export control laws, including identification and reporting of all exports and re-exports of controlled technology or exports made without correct license approval or improper license use could result in severe penalties and revocation of licenses. Failure to obtain export licenses, delays in obtaining licenses, or revocation of previously issued licenses would prevent us from selling the affected products outside the United States and could negatively impact our results of operations.

The Photonics business is dependent on U.S. government contracts, which are subject to fixed pricing, immediate termination and a number of procurement rules and regulations.

We sell our Photonics products and services directly to the U.S. government, as well as to prime contractors for various U.S. government programs. The U.S government is considering significant changes in the level of existing, follow-on or replacement programs. We cannot predict the impact of potential changes in priorities due to military transformations and/or the nature of future war-related activities. A shift of government priorities to programs in which we do not participate and/or reductions in funding for or the termination of programs in which we do participate, unless offset by other programs and opportunities, could have a material adverse effect on our financial position, results of operations, or cash flows.

Funding of multi-year government programs is subject to congressional appropriations, and there is no guarantee that the U.S. government will make further appropriations, particularly given the U.S. government’s recent focus on spending in other areas and spending reductions. Sales to the U.S. government and its prime contractors may also be affected by changes in procurement policies, budget considerations and political developments in the United States or abroad. For example, if the U.S. government is less focused on defense spending or there is a decrease in hostilities, demand for our products could decrease. The loss of funding for a government program would result in a loss of future revenues attributable to that program. The influence of any of these factors, which are beyond our control, could negatively impact our results of operations.

34

A significant portion of our U.S. government revenue is derived from fixed-price development and production contracts. Under fixed-price contracts, unexpected increases in the cost to develop or manufacture a product, whether due to inaccurate estimates in the bidding process, unanticipated increases in material costs, reduced production volumes, inefficiencies or other factors, are borne by us. We have experienced cost overruns in the past that have resulted in losses on certain contracts, and may experience additional cost overruns in the future. We are required to recognize the total estimated impact of cost overruns in the period in which they are first identified. Such cost overruns could have a material adverse effect on our results of operations.

Generally, government contracts contain provisions permitting termination, in whole or in part, without prior notice at the government’s convenience upon the payment of compensation only for work done and commitments made at the time of termination. We cannot ensure that one or more of the government contracts under which we, or our customers, operate will not be terminated under these circumstances. Also, we cannot ensure that we, or our customers, would be able to procure new government contracts to offset the revenues lost as a result of any termination of existing contracts, nor can we ensure that we, or our customers, will continue to remain in good standing as federal contractors.

As a U.S. government contractor we must comply with specific government rules and regulations and are subject to routine audits and investigations by U.S. government agencies. If we fail to comply with these rules and regulations, the results could include: (1) reductions in the value of our contracts; (2) reductions in amounts previously billed and recognized as revenue; (3) contract modifications or termination; (4) the assessment of penalties and fines; and (5) suspension or debarment from government contracting or subcontracting for a period of time or permanently.

Changes to our effective tax rate affect our results of operations.

As a global company, we are subject to taxation in the United States, Singapore and various other countries. Significant judgment is required to determine and estimate worldwide tax liabilities. Our future effective tax rate could be affected by: (1) changes in tax laws; (2) the allocation of earnings to countries with differing tax rates; (3) changes in worldwide projected annual earnings in current and future years: (4) accounting pronouncements; or (5) changes in the valuation of our deferred tax assets and liabilities. Although we believe our tax estimates are reasonable, there can be no assurance that any final determination will not be different from the treatment reflected in our historical income tax provisions and accruals, which could result in additional payments by Intevac.

Our success depends on international sales and the management of global operations.

In previous years, the majority of our revenues have come from regions outside the United States. Most of our international sales are to customers in Asia, which includes products shipped to overseas operations of U.S. companies. We currently have manufacturing facilities in California and Singapore and international customer support offices in Singapore, China, and Malaysia. We expect that international sales will continue to account for a significant portion of our total revenue in future years. Certain of our suppliers are also located outside the United States.

Managing our global operations presents challenges including, but not limited to, those arising from: (1) global trade issues; (2) variations in protection of intellectual property and other legal rights in different countries; (3) concerns of U.S. governmental agencies regarding possible national commercial and/or security issues posed by growing manufacturing business in Asia; (4) fluctuation of interest rates, raw material costs, labor and operating costs, and exchange rates; (5) variations in the ability to develop relationships with suppliers and other local businesses; (6) changes in the laws and regulations of the United States, including export restrictions, and other countries, as well as their interpretation and application; (7) the need to provide technical and spares support in different locations; (8) political and economic instability; (9) cultural differences; (10) varying government incentives to promote development; (11) shipping costs and delays; (12) adverse conditions in credit markets; (13) variations in tariffs, quotas, tax codes and other market barriers; and (14) barriers to movement of cash.

35

We must regularly assess the size, capability and location of our global infrastructure and make appropriate changes to address these issues.

Difficulties in integrating past or future acquisitions could adversely affect our business.

We have completed a number of acquisitions and dispositions during our operating history. For example, in 2007, we acquired certain assets of DeltaNu, LLC and certain assets of Creative Display Systems, LLC, in 2008 we acquired certain assets of OC Oerlikon Balzers Ltd., in 2010 we acquired the outstanding shares of SIT, in 2012 we completed the sale of certain semiconductor mainframe technology assets and in 2013 we completed the sale of the assets of DeltaNu. We have spent and may continue to spend significant resources identifying and pursuing future acquisition opportunities. Acquisitions involve numerous risks including: (1) difficulties in integrating the operations, technologies and products of the acquired companies or achieving the desires outcomes; (2) the diversion of our management’s attention from other business concerns; and (3) the potential loss of key employees of the acquired companies. Failure to achieve the anticipated benefits of the prior and any future acquisitions or to successfully integrate the operations of the companies we acquire could have a material and adverse effect on our business, financial condition and results of operations. Any future acquisitions could also result in potentially dilutive issuance of equity securities, acquisition or divestiture-related write-offs or the assumption of debt and contingent liabilities. In addition, we have made and will continue to consider making strategic divestitures. With any divestiture, there are risks that future operating results could be unfavorably impacted if targeted objectives, such as cost savings, are not achieved or if other business disruptions occur as a result of the divestiture or activities related to the divestiture.

We may be subject to additional impairment charges due to potential declines in the fair value of our assets.

As a result of our acquisitions, we have significant intangible assets and had significant goodwill on our balance sheet. We test these assets for impairment on a periodic basis as required, and whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The events or changes that could require us to test our intangible assets for impairment include: a significant reduction in our stock price, and as a result market capitalization, changes in our estimated future cash flows, as well as changes in rates of growth in our industry or in any of our reporting units. In the fourth quarter of 2012, as a result of a decline in our market capitalization and a reduction in our revenue expectations we recorded a goodwill impairment charge in the amount of $18.4 million. We will continue to evaluate the carrying value of our intangible assets and if we determine in the future that there is a potential further impairment, we may be required to record additional charges to earnings which could materially adversely affect our financial results and could also materially adversely affect our business.

Our success is dependent on recruiting and retaining a highly talented work force.

Our employees are vital to our success, and our key management, engineering and other employees are difficult to replace. We do not maintain key person life insurance on any of our employees. The expansion of high technology companies worldwide has increased demand and competition for qualified personnel, and has made companies increasingly protective of prior employees. It may be difficult for us to locate employees who are not subject to non-competition agreements and other restrictions.

The majority of our U.S. operations are located in California where the cost of living and of recruiting employees is high. Our operating results depend, in large part, upon our ability to retain and attract qualified management, engineering, marketing, manufacturing, customer support, sales and administrative personnel. Furthermore, we compete with industries such as the hard disk drive, semiconductor, and solar industries for skilled employees. Failure to retain existing key personnel, or to attract, assimilate or retain additional highly qualified employees to meet our needs in the future, could have a material and adverse effect on our business, financial condition and results of operations.

36

We are dependent on certain suppliers for parts used in our products.

We are a manufacturing business. Purchased parts constitute the largest component of our product cost. Our ability to manufacture depends on the timely delivery of parts, components and subassemblies from suppliers. We obtain some of the key components and subassemblies used in our products from a single supplier or a limited group of suppliers. If any of our suppliers fail to deliver quality parts on a timely basis, we may experience delays in manufacturing, which could result in delayed product deliveries, increased costs to expedite deliveries or develop alternative suppliers, or require redesign of our products to accommodate alternative suppliers. Some of our suppliers are thinly capitalized and may be vulnerable to failure.

Our business depends on the integrity of our intellectual property rights.

The success of our business depends upon the integrity of our intellectual property rights, and we cannot ensure that: (1) any of our pending or future patent applications will be allowed or that any of the allowed applications will be issued as patents or will issue with claims of the scope we sought; (2) any of our patents will not be invalidated, deemed unenforceable, circumvented or challenged; (3) the rights granted under our patents will provide competitive advantages to us; (4) other parties will not develop similar products, duplicate our products or design around our patents; or (5) our patent rights, intellectual property laws or our agreements will adequately protect our intellectual property or competitive position.

From time to time, we have received claims that we are infringing third parties’ intellectual property rights or seeking to invalidate our rights. We cannot ensure that third parties will not in the future claim that we have infringed current or future patents, trademarks or other proprietary rights relating to our products. Any claims, with or without merit, could be time-consuming, result in costly litigation, cause product shipment delays or require us to enter into royalty or licensing agreements. Such royalty or licensing agreements, if required, may not be available on terms acceptable to us.

We could be involved in litigation.

From time to time we may be involved in litigation of various types, including litigation alleging infringement of intellectual property rights and other claims. Litigation is expensive, subjects us to the risk of significant damages and requires significant management time and attention and could have a material and adverse effect on our business, financial condition and results of operations.

We are subject to risks of non-compliance with environmental and other governmental regulations.

We are subject to a variety of governmental regulations relating to the use, storage, discharge, handling, emission, generation, manufacture, treatment and disposal of toxic or otherwise hazardous substances, chemicals, materials or waste. If we fail to comply with current or future regulations, such failure could result in suspension of our operations, alteration of our manufacturing process, remediation costs or substantial civil penalties or criminal fines against us or our officers, directors or employees. Additionally, these regulations could require us to acquire expensive remediation or abatement equipment and to incur substantial expenses to comply with them.

We are also subject to a variety of other governmental regulations and may incur significant costs associated with the compliance with these regulations. For example rules adopted by the SEC to implement the Dodd-Frank Wall Street Reform and Consumer Protection Act impose diligence and disclosure requirements regarding the use of “conflict” minerals mined from the Democratic Republic of Congo and adjoining countries in the products we manufacture. Compliance with these regulations is likely to result in additional costs and expenses or may affect the sourcing and availability of the components used in the products we manufacture.

Business interruptions could adversely affect our operations.

Our operations are vulnerable to interruption by fire, earthquake, floods or other natural disaster, quarantines or other disruptions associated with infectious diseases, national catastrophe, terrorist activities, war, disruptions in our computing and communications infrastructure due to power loss, telecommunications failure, human error, physical

37

or electronic security breaches and computer viruses, and other events beyond our control. We do not have a detailed disaster recovery plan. Despite our implementation of network security measures, our tools and servers may be vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering with our computer systems and tools located at customer sites. Political instability could cause us to incur increased costs in transportation, make such transportation unreliable, increase our insurance costs or cause international currency markets to fluctuate. All these unforeseen disruptions and instabilities could have the same effects on our suppliers and their ability to timely deliver their products. In addition, we do not carry sufficient business interruption insurance to compensate us for all losses that may occur, and any losses or damages incurred by us could have a material adverse effect on our business and results of operations. For example, we self-insure earthquake risks because we believe this is the prudent financial decision based on the high cost of the limited coverage available in the earthquake insurance market. An earthquake could significantly disrupt our operations, most of which are conducted in California. It could also significantly delay our research and engineering effort on new products, most of which is also conducted in California. We take steps to minimize the damage that would be caused by business interruptions, but there is no certainty that our efforts will prove successful.

We could be negatively affected as a result of a proxy contest and the actions of activist stockholders.

A proxy contest with respect to election of our directors, or other activist stockholder activities, could adversely affect our business because: (i) responding to a proxy contest and other actions by activist stockholders can be costly and time-consuming, disruptive to our operations and divert the attention of management and our employees; (ii) perceived uncertainties as to our future direction caused by activist activities may result in the loss of potential business opportunities, and may make it more difficult to attract and retain qualified personnel and business partners; and (iii) if individuals are elected to our Board of Directors with a specific agenda, it may adversely affect our ability to effectively and timely implement our strategic plans.

We are required to evaluate our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, and any adverse results from such evaluation could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock price.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, our management must perform evaluations of our internal control over financial reporting. Beginning in 2004, our Form 10-K has included a report by management of their assessment of the adequacy of such internal control. Additionally, our independent registered public accounting firm must publicly attest to the effectiveness of our internal control over financial reporting.

We have completed the evaluation of our internal controls over financial reporting as required by Section 404 of the Sarbanes-Oxley Act. Although our assessment, testing, and evaluation resulted in our conclusion that as of December 31, 2016, our internal controls over financial reporting were effective, we cannot predict the outcome of our testing in future periods. Ongoing compliance with this requirement is complex, costly and time-consuming. If Intevac fails to maintain effective internal control over financial reporting; our management does not timely assess the adequacy of such internal control; or our independent registered public accounting firm does not deliver an unqualified opinion as to the effectiveness of our internal control over financial reporting, then we could be subject to restatement of previously reported financial results, regulatory sanctions and a decline in the public’s perception of Intevac, which could have a material and adverse effect on our business, financial condition and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. At September 30, 2017, $1.5 million remains available for future stock repurchases under the repurchase program. Intevac did not make any common stock repurchases during the three months ended September 30, 2017.

Item 3. Defaults upon Senior Securities

None.

38

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed herewith:

Exhibit Number	Description
31.1	Certification of President and Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Executive Vice President, Finance and Administration, Chief Financial Officer, Treasurer and Secretary Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certifications Pursuant to U.S.C. 1350 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

39

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	INTEVAC, INC.
Date: October 31, 2017	By:	/s/ WENDELL BLONIGAN
		Wendell Blonigan
		President, Chief Executive Officer and Director (Principal Executive Officer)

Date: October 31, 2017	By:	/s/ JAMES MONIZ
		James Moniz
		Executive Vice President, Finance and Administration, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)

40

EX-31.1

Exhibit 31.1

I, Wendell Blonigan certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 31, 2017

/s/ WENDELL BLONIGAN

Wendell Blonigan

President, Chief Executive Officer and Director

EX-31.2

Exhibit 31.2

I, James Moniz certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Intevac, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 31, 2017

/s/ JAMES MONIZ

James Moniz

Executive Vice President, Finance and Administration,

Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Wendell Blonigan, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Intevac, Inc. on Form 10-Q for the quarterly period ended September 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Intevac, Inc.

Date: October 31, 2017

/s/ WENDELL BLONIGAN

Wendell Blonigan

President, Chief Executive Officer and Director

I, James Moniz, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Intevac, Inc. on Form 10-Q for the quarterly period ended September 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Intevac, Inc.

Date: October 31, 2017

/s/ JAMES MONIZ

James Moniz

Executive Vice President, Finance and Administration, Chief Financial Officer and Treasurer

A signed original of this written statement required by Section 906 has been provided to Intevac, Inc. and will be retained by Intevac, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Oct. 31, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q3
Trading Symbol	IVAC
Entity Registrant Name	INTEVAC INC
Entity Central Index Key	0001001902
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		21,789,007

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 19,197	$ 27,043
Short-term investments	18,037	17,602
Trade and other accounts receivable, net of allowances of $0 at both September 30, 2017 and at December 31, 2016	22,311	17,447
Inventories	32,581	24,876
Prepaid expenses and other current assets	2,825	1,768
Total current assets	94,951	88,736
Property, plant and equipment, net	12,509	11,237
Long-term investments	6,165	3,593
Restricted cash	1,400	1,602
Intangible assets, net of amortization of $6,725 at September 30, 2017 and $6,129 at December 31, 2016	1,662	2,258
Deferred income taxes and other long-term assets	745	898
Total assets	117,432	108,324
Current liabilities:
Accounts payable	7,036	5,323
Accrued payroll and related liabilities	5,781	4,220
Other accrued liabilities	7,856	17,011
Customer advances	12,347	5,422
Total current liabilities	33,020	31,976
Other long-term liabilities	2,994	3,082
Stockholders' equity:
Common stock, $0.001 par value	22	21
Additional paid-in capital	176,282	171,314
Treasury stock, 4,845 shares at both September 30, 2017 and December 31, 2016	(28,489)	(28,489)
Accumulated other comprehensive income	443	321
Accumulated deficit	(66,840)	(69,901)
Total stockholders' equity	81,418	73,266
Total liabilities and stockholders' equity	$ 117,432	$ 108,324

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Net of allowances of trade, note and other accounts receivable	$ 0	$ 0
Net of amortization of intangible assets	$ 6,725	$ 6,129
Common stock, par value	$ 0.001	$ 0.001
Treasury stock, shares	4,845	4,845

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Net revenues:
Systems and components	$ 24,537	$ 20,961	$ 82,822	$ 47,326
Technology development	2,189	1,598	5,255	3,816
Total net revenues	26,726	22,559	88,077	51,142
Cost of net revenues:
Systems and components	13,402	13,025	47,419	29,490
Technology development	2,026	1,019	4,842	3,155
Total cost of net revenues	15,428	14,044	52,261	32,645
Gross profit	11,298	8,515	35,816	18,497
Operating expenses:
Research and development	4,535	4,067	13,635	14,220
Selling, general and administrative	5,495	4,772	17,482	14,724
Total operating expenses	10,030	8,839	31,117	28,944
Income (loss) from operations	1,268	(324)	4,699	(10,447)
Interest income and other income (expense), net	28	60	265	184
Income (loss) before income taxes	1,296	(264)	4,964	(10,263)
Provision for income taxes	66	217	805	13
Net income (loss)	$ 1,230	$ (481)	$ 4,159	$ (10,276)
Net income (loss) per share:
Basic	$ 0.06	$ (0.02)	$ 0.19	$ (0.50)
Diluted	$ 0.05	$ (0.02)	$ 0.18	$ (0.50)
Weighted average common shares outstanding:
Basic	21,714	20,869	21,475	20,704
Diluted	22,970	20,869	22,989	20,704

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Net income (loss)	$ 1,230	$ (481)	$ 4,159	$ (10,276)
Other comprehensive income (loss), before tax
Change in unrealized net gain on available-for-sale investments	5	(16)	8	41
Foreign currency translation gains (losses)	39	(17)	114	5
Other comprehensive income (loss), before tax	44	(33)	122	46
Income tax (expense) benefit related to items in other comprehensive income (loss)	0	0	0	0
Other comprehensive income (loss), net of tax	44	(33)	122	46
Comprehensive income (loss)	$ 1,274	$ (514)	$ 4,281	$ (10,230)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016
Operating activities
Net income (loss)	$ 4,159	$ (10,276)
Adjustments to reconcile net income (loss) to net cash and cash equivalents used in operating activities:
Depreciation and amortization	2,877	3,744
Net amortization of investment premiums and discounts	53	96
Equity-based compensation	3,012	2,896
Change in the fair value of acquisition-related contingent consideration	(181)	(90)
Deferred income taxes	(1)	9
Gain on disposal of equipment		(8)
Changes in operating assets and liabilities	(11,658)	577
Total adjustments	(5,898)	7,224
Net cash and cash equivalents used in operating activities	(1,739)	(3,052)
Investing activities
Purchases of investments	(21,968)	(10,433)
Proceeds from sales and maturities of investments	18,916	22,180
Proceeds from sale of equipment		8
Purchases of leasehold improvements and equipment	(3,553)	(2,535)
Decrease (increase) in restricted cash	202	(178)
Net cash and cash equivalents (used in) provided by investing activities	(6,403)	9,042
Financing activities
Net proceeds from issuance of common stock	2,344	1,482
Taxes paid related to net share settlement	(1,988)	(403)
Payment of acquisition-related contingent consideration	(174)
Net cash and cash equivalents provided by financing activities	182	1,079
Effect of exchange rate changes on cash	114	8
Net increase (decrease) in cash and cash equivalents	(7,846)	7,077
Cash and cash equivalents at beginning of period	27,043	13,746
Cash and cash equivalents at end of period	$ 19,197	$ 20,823

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2017

Basis of Presentation

1. Basis of Presentation

In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac, Inc. and its subsidiaries (“Intevac” or the “Company”) included herein have been prepared on a basis consistent with the December 31, 2016 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. These unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in Intevac’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (“2016 Form 10-K”). Intevac’s results of operations for the three and nine months ended September 30, 2017 are not necessarily indicative of future operating results.

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make judgments, estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ materially from those estimates.

XML

Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2017

Recent Accounting Pronouncements

2. Recent Accounting Pronouncements

In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-09, Compensation—Stock Compensation: Scope of Modification Accounting, which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. An entity will account for the effects of a modification unless the fair value of the modified award is the same as the original award, the vesting conditions of the modified award are the same as the original award and the classification of the modified award as an equity instrument or liability instrument is the same as the original award. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2019. The update is to be adopted prospectively to an award modified on or after the adoption date. Early adoption is permitted. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.

In March 2017, the FASB issued ASU 2017-08, Receivables – Nonrefundable Fees and Other Costs (Subtopic 310-20): Premium Amortization on Purchased Callable Debt Securities. ASU 2017-08 amends the amortization period for certain purchased callable debt securities held at a premium, shortening such period to the earliest call date. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2019. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. ASU 2017-04 eliminates Step 2 from the goodwill impairment test. Under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in ASU 2017-04, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. This update becomes effective and will be adopted by Intevac in the first quarter of fiscal 2020. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. Intevac does not expect the adoption of this update to have a material impact on its consolidated financial statements.

In March 2016, the FASB issued ASU 2016-09 Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. We have adopted these amendments beginning in the first quarter of 2017. Starting in the first quarter of fiscal 2017, stock-based compensation excess tax benefits or deficiencies are reflected in the Condensed Consolidated Statements of Operations as a component of the provision for income taxes, whereas they previously were recognized in equity. Additionally, our Condensed Consolidated Statements of Cash Flows now presents excess tax benefits as an operating activity. Finally, we have elected to account for forfeitures as they occur, rather than estimate expected forfeitures. The net cumulative effect of this change was recognized as a $1.1 million charge to the accumulated deficit as of January 1, 2017.

In May 2014, the FASB issued ASU 2014-09 (Topic 606) Revenue from Contracts with Customers. Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, “Revenue Recognition”, and requires entities to recognize revenue when they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods or services. We expect revenue recognition for our equipment sales arrangements, which includes systems, technology upgrades, service and spare parts, to remain materially consistent with our historical practice.

We expect to recognize revenue for equipment sales at a point in time following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts. Our contracts with customers may include multiple performance obligations. For such arrangements, we expect to allocate revenue to each performance obligation based on its relative standalone selling price. We generally determine standalone selling prices based on the prices charged to customers or using expected cost plus margin. The expected costs associated with our base warranties will continue to be recognized as expense when the equipment is sold.

We expect to recognize revenue for cost plus fixed fee and firm fixed priced government contracts over time under the cost-to-cost method for the majority of our government contracts, which is consistent with our current revenue recognition model. Revenue on the majority of our government contracts will continue to be recognized over time because of the continuous transfer of control to the customer. For U.S. government contracts, this continuous transfer of control to the customer is supported by clauses in the contract that allow the customer to unilaterally terminate the contract for convenience, pay us for costs incurred plus a reasonable profit and take control of any work in process. Similarly, for non-U.S. government contracts, the customer typically controls the work in process as evidenced either by contractual termination clauses or by our rights to payment for work performed to date to deliver products or services that do not have an alternative use to the company. Under the new standard, the cost-to-cost measure of progress continues to best depict the transfer of control of assets to the customer, which occurs as we incur costs.

The new standard must be adopted by Intevac in our fiscal year beginning December 31, 2017. We intend to adopt the new standard as of December 31, 2017, using the modified retrospective transition method applied to those contracts which were not completed as of that date. Upon adoption, we will recognize the cumulative effect of adopting this guidance as an adjustment to our opening balance of the accumulated deficit. Prior periods will not be retrospectively adjusted. Based on our preliminary assessment, we expect the adoption of Topic 606 will not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated Statements of Operations. We also do not expect the standard to have a material impact on our Consolidated Balance Sheet. The immaterial impact primarily relates to reclassifications among financial statement accounts to align with the new standard. Most notably, contracts in process, net will be reclassified as receivables or contract assets based on amounts billed or unbilled, respectively. Advance payments and billings in excess of costs incurred and deferred revenue will be combined and reclassified as contract liabilities. Our contract balances will be reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.

XML

Inventories

9 Months Ended

Sep. 30, 2017

Inventories

3. Inventories

Inventories are stated at the lower of average cost or market and consist of the following:

	September 30,		December 31,
	2017		2016
	(In thousands)
Raw materials	$	16,385	$	10,290
Work-in-progress		12,452		6,470
Finished goods		3,744		8,116
	$	32,581	$	24,876

Finished goods inventory consists primarily of completed systems that are undergoing installation and acceptance testing.

XML

Equity-Based Compensation

9 Months Ended

Sep. 30, 2017

Equity-Based Compensation

4. Equity-Based Compensation

At September 30, 2017, Intevac had equity-based awards outstanding under the 2012 Equity Incentive Plan and the 2004 Equity Incentive Plan (together, the “Plans”) and the 2003 Employee Stock Purchase Plan (the “ESPP”). Intevac’s stockholders approved all of these plans. The Plans permit the grant of incentive or non-statutory stock options, restricted stock, stock appreciation rights, restricted stock units (“RSUs”) and performance shares.

The ESPP provides that eligible employees may purchase Intevac’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market value at the entry date of the applicable offering period or at the end of each applicable purchase interval. Offering periods are generally two years in length, and consist of a series of six-month purchase intervals. Eligible employees may join the ESPP at the beginning of any six-month purchase interval. Under the terms of the ESPP, employees can choose to have up to 15% of their base earnings withheld to purchase Intevac common stock.

Compensation Expense

The effect of recording equity-based compensation for the three and nine months ended September 30, 2017 and October 1, 2016 was as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Equity-based compensation by type of award:
Stock options	$	350	$	211	$	808	$	696
RSUs		731		543		1,943		1,657
ESPP awards		67		151		261		543
Total equity-based compensation	$	1,148	$	905	$	3,012	$	2,896

Equity-based compensation expense is based on awards ultimately expected to vest and such amount has been historically reduced for estimated forfeitures. Beginning January 1, 2017, Intevac accounts for forfeitures as they occur, rather than estimating expected forfeitures. The net cumulative effect of this change was recognized as a $1.1 million increase to the accumulated deficit as of January 1, 2017.

Stock Options and ESPP

The fair value of stock options and ESPP awards is estimated at the grant date using the Black-Scholes option valuation model. The determination of fair value of stock options and ESPP awards on the date of grant using an option-pricing model is affected by Intevac’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards and actual employee stock option exercise behavior.

Option activity as of September 30, 2017 and changes during the nine months ended September 30, 2017 were as follows:

	Shares			Weighted Average Exercise Price
Options outstanding at December 31, 2016		2,740,364		$	7.00
Options granted		413,075		$	12.33
Options cancelled and forfeited		(61,753	)	$	12.07
Options exercised		(115,273	)	$	6.88
Options outstanding at September 30, 2017		2,976,413		$	7.64
Options exercisable at September 30, 2017		2,127,940		$	7.16

Intevac issued 405,659 shares under the ESPP during the nine months ended September 30, 2017.

Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
Stock Options:
Weighted-average fair value of grants per share	$	3.89		$	1.90		$	4.54		$	1.75
Expected volatility		42.10	%		40.53	%		40.54	%		44.00	%
Risk free interest rate		1.84	%		0.97	%		1.77	%		0.94	%
Expected term of options (in years)		4.08			3.96			4.10			4.29
Dividend yield		None			None			None			None
	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
Stock Purchase Rights:
Weighted-average fair value of grants per share	$	2.76		$	1.69		$	2.75		$	1.55
Expected volatility		48.59	%		37.51	%		43.51	%		39.22	%
Risk free interest rate		1.36	%		0.63	%		1.22	%		0.75	%
Expected term of purchase rights (in years)		0.50			1.00			0.65			1.87
Dividend yield		None			None			None			None

The computation of the expected volatility assumptions used in the Black-Scholes calculations for new stock option grants and employee stock purchase rights is based on the historical volatility of Intevac’s stock price, measured over a period equal to the expected term of the stock option grant or purchase right. The risk-free interest rate is based on the yield available on U.S. Treasury Strips with an equivalent remaining term. The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the equity-based awards and vesting schedules. The expected term of purchase rights represents the period of time remaining in the current offering period. The dividend yield assumption is based on Intevac’s history of not paying dividends and the assumption of not paying dividends in the future.

RSUs

A summary of the RSU activity is as follows:

	Shares			Weighted Average Grant Date Fair Value
Non-vested RSUs at December 31, 2016		949,455		$	4.64
Granted		363,846		$	11.44
Vested		(500,621	)	$	4.46
Cancelled and forfeited		(14,292	)	$	7.97
Non-vested RSUs at September 30, 2017		798,388		$	7.79

Time-based RSUs are converted into shares of Intevac common stock upon vesting on a one-for-one basis. Time-based RSUs typically are scheduled to vest over three or four years. Vesting of time-based RSUs is subject to the grantee’s continued service with Intevac. The compensation expense related to these awards is determined using the fair market value of Intevac common stock on the date of the grant, and the compensation expense is recognized over the vesting period.

Market condition-based RSUs vest upon the achievement of certain market conditions (our stock performance) during a set performance period (typically five years) subject to the grantee’s continued service with Intevac through the date the applicable market condition is achieved. The fair value is based on the values calculated under the Monte Carlo simulation model on the grant date. Compensation cost is not adjusted in future periods for subsequent changes in the expected outcome of market related conditions. The compensation expense is recognized over the derived service period. We granted 125,000 of such awards to certain executive officers in the nine months ended October 1, 2016. These awards have a derived service period of 2.8 years.

Intevac estimated the weighted-average fair value of market condition-based RSUs using the following weighted-average assumptions:

	Nine Months Ended October 1, 2016
Weighted-average fair value of grants per share	$	2.46
Expected volatility		47.65	%
Risk free interest rate		1.35	%
Expected term (in years)		4.79
Dividend yield		None

In fiscal 2016, the annual bonus for certain participants in the Company’s annual incentive plan was settled with RSUs with one year vesting. The Company accrued for the payment of bonuses at the expected company-wide payout percentage amount at October 1, 2016, which amounts were less than the target bonus amounts for each participant. The bonus accrual was classified as a liability until the number of shares was determined on the date the awards were granted, at which time the Company classified the awards into equity. In February 2017, the annual 2016 bonus for certain participants was settled with RSUs with one-year vesting. 33 participants were granted stock awards to receive an aggregate of 134,000 shares of common stock with a weighted average grant date fair value of $9.63 per share. In February 2016, the annual 2015 bonus for certain participants was settled with RSUs with one year vesting. 34 participants were granted stock awards to receive an aggregate of 266,000 shares of common stock with a weighted average grant date fair value of $4.40 per share. The Company recorded equity-based compensation expense related to the annual incentive plans of $102,000 for the nine months ended September 30, 2017. The Company recorded equity-based compensation expense related to the annual incentive plan of $120,000 and $364,000, respectively, for the three and nine months ended October 1, 2016.

XML

Purchased Intangible Assets

9 Months Ended

Sep. 30, 2017

Purchased Intangible Assets

5. Purchased Intangible Assets

Details of finite-lived intangible assets by segment as of September 30, 2017 are as follows.

	September 30, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
Equipment	$	7,172	$	(5,648	)	$	1,524
Photonics		1,215		(1,077	)		138
	$	8,387	$	(6,725	)	$	1,662

Total amortization expense of finite-lived intangibles for the three and nine months ended September 30, 2017 was $169,000 and $596,000, respectively.

As of September 30, 2017, future amortization expense is expected to be as follows.

(In thousands)
2017	$	159
2018		615
2019		615
2020		273
	$	1,662

XML

Acquisition-Related Contingent Consideration

9 Months Ended

Sep. 30, 2017

Acquisition-Related Contingent Consideration

6. Acquisition-Related Contingent Consideration

In connection with the acquisition of Solar Implant Technologies, Inc. (“SIT”), Intevac agreed to pay to the selling shareholders in cash a revenue earnout on Intevac’s net revenue from commercial sales of certain products over a specified period up to an aggregate of $9.0 million. Intevac estimated the fair value of this contingent consideration on September 30, 2017 based on probability-based forecasted revenues reflecting Intevac’s own assumptions concerning future revenue from such products.

The fair value measurement of contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Any change in fair value of the contingent consideration subsequent to the acquisition date is recognized in income (loss) from operations within the condensed consolidated statement of operations. The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the three and nine month periods ended September 30, 2017 and October 1, 2016:

	Three Months Ended					Nine Months Ended
	September 30, 2017			October 1, 2016		September 30, 2017			October 1, 2016
	(In thousands)
Opening balance	$	859		$	748	$	759		$	890
Changes in fair value		(283	)		52		(181	)		(90	)
Cash payments made		(172	)		—		(174	)		—
Closing balance	$	404		$	800	$	404		$	800

The following table displays the balance sheet classification of the contingent consideration liability account at September 30, 2017 and at December 31, 2016:

	September 30,		December 31,
	2017		2016
	(In thousands)
Other accrued liabilities	$	36	$	329
Other long-term liabilities		368		430
Total acquisition-related contingent consideration	$	404	$	759

The following table represents the quantitative range of the significant unobservable inputs used in the calculation of fair value of the continent consideration liability as of September 30, 2017. Significant increases or decreases in any of these inputs in isolation would result in a significantly lower or higher fair value measurement.

	Quantitative Information about Level 3 Fair Value Measurements at September 30, 2017
	Fair Value		Valuation Technique	Unobservable Input	Range (Weighted Average)
	(In thousands, except for percentages)
Revenue Earnout	$	404	Discounted cash flow	Weighted average cost of capital Probability weighting of achieving revenue forecasts	11.9% 10.0% - 80.0% (30.0%)

XML

Warranty

9 Months Ended

Sep. 30, 2017

Warranty

7. Warranty

Intevac provides for the estimated cost of warranty when revenue is recognized. Intevac’s warranty is per contract terms and for its disk manufacturing, solar photovoltaic (“PV”) manufacturing and display cover panel (“DCP”) manufacturing systems the warranty typically ranges between 12 and 24 months from customer acceptance. During this warranty period any defective non-consumable parts are replaced and installed at no charge to the customer. Intevac uses estimated repair or replacement costs along with its historical warranty experience to determine its warranty obligation. Intevac generally provides a twelve month warranty on its Photonics products. The provision for the estimated future costs of warranty is based upon historical cost and product performance experience. Intevac exercises judgment in determining the underlying estimates.

On the condensed consolidated balance sheets, the short-term portion of the warranty provision is included in other accrued liabilities, while the long-term portion is included in other long-term liabilities. The expense associated with product warranties issued or adjusted is included in cost of net revenues on the condensed consolidated statements of operations.

The following table displays the activity in the warranty provision account for the three and nine months ended September 30, 2017 and October 1, 2016:

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
	(In thousands)
Opening balance	$	1,220		$	592		$	1,007		$	982
Expenditures incurred under warranties		(360	)		(80	)		(640	)		(384	)
Accruals for product warranties issued during the reporting period		169			320			675			494
Adjustments to previously existing warranty accruals		106			(110	)		93			(370	)
Closing balance	$	1,135		$	722		$	1,135		$	722

The following table displays the balance sheet classification of the warranty provision account at September 30, 2017 and at December 31, 2016:

	September 30, 2017		December 31, 2016
	(In thousands)
Other accrued liabilities	$	915	$	829
Other long-term liabilities		220		178
Total warranty provision	$	1,135	$	1,007

XML

Guarantees

9 Months Ended

Sep. 30, 2017

Guarantees

8. Guarantees

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, Intevac has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at Intevac’s request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The maximum potential amount of future payments Intevac could be required to make under these indemnification obligations is unlimited; however, Intevac has a director and officer insurance policy that mitigates Intevac’s exposure and enables Intevac to recover a portion of any future amounts paid. As a result of Intevac’s insurance policy coverage, Intevac believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in Intevac’s industry, many of Intevac’s contracts provide remedies to certain third parties such as defense, settlement, or payment of judgments for intellectual property claims related to the use of its products. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.

Letters of Credit

As of September 30, 2017, we had letters of credit and bank guarantees outstanding totaling $1.4 million, including a standby letter of credit outstanding under the Santa Clara, California facility lease and various other guarantees with our bank. These letters of credit and bank guarantees are collateralized by $1.4 million of restricted cash.

XML

Cash, Cash Equivalents and Investments

9 Months Ended

Sep. 30, 2017

Cash, Cash Equivalents and Investments

9. Cash, Cash Equivalents and Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

	September 30, 2017
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	14,159	$	—	$	—	$	14,159
Money market funds		5,038		—		—		5,038
Total cash and cash equivalents	$	19,197	$	—	$	—	$	19,197
Short-term investments:
Certificates of deposit	$	4,498	$	1	$	1	$	4,498
Commercial paper		1,990		—		—		1,990
Corporate bonds and medium-term notes		6,252		1		5		6,248
Municipal bonds		1,004		—		3		1,001
U.S. treasury and agency securities		4,300		—		—		4,300
Total short-term investments	$	18,044	$	2	$	9	$	18,037
Long-term investments:
Corporate bonds and medium-term notes	$	3,576	$	—	$	3	$	3,573
U.S. treasury and agency securities		2,596		—		4		2,592
Total long-term investments	$	6,172	$	—	$	7	$	6,165
Total cash, cash equivalents, and investments	$	43,413	$	2	$	16	$	43,399
	December 31, 2016
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(in thousands)
Cash and cash equivalents:
Cash	$	18,726	$	—	$	—	$	18,726
Money market funds		8,317		—		—		8,317
Total cash and cash equivalents	$	27,043	$	—	$	—	$	27,043
Short-term investments:
Commercial paper	$	1,992	$	—	$	1	$	1,991
Corporate bonds and medium-term notes		8,586		—		6		8,580
Municipal bonds		600		—		—		600
U.S. treasury and agency securities		6,432		—		1		6,431
Total short-term investments	$	17,610	$	—	$	8	$	17,602
Long-term investments:
Corporate bonds and medium-term notes	$	2,510	$	—	$	11	$	2,499
Municipal bonds		500		—		4		496
U.S. treasury and agency securities		597		1		—		598
Total long-term investments	$	3,607	$	1	$	15	$	3,593
Total cash, cash equivalents, and investments	$	48,260	$	1	$	23	$	48,238

The contractual maturities of available-for-sale securities at September 30, 2017 are presented in the following table.

	Amortized Cost		Fair Value
	(In thousands)
Due in one year or less	$	23,082	$	23,075
Due after one through two years		6,172		6,165
	$	29,254	$	29,240

The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of September 30, 2017.

	September 30, 2017
	In Loss Position for Less than 12 Months				In Loss Position for Greater than 12 Months
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(In thousands)
Certificates of deposit	$	1,249	$	1	$	—	$	—
Corporate bonds and medium-term notes		5,882		7		1,200		1
Municipal bonds		504		1		497		2
U.S. treasury and agency securities		4,118		4		—		—
	$	11,753	$	13	$	1,697	$	3

All prices for the fixed maturity securities including U.S. Treasury and agency securities, certificates of deposit, commercial paper, corporate bonds and municipal bonds are received from independent pricing services utilized by Intevac’s outside investment manager. This investment manager performs a review of the pricing methodologies and inputs utilized by the independent pricing services for each asset type priced by the vendor. In addition, on at least an annual basis, the investment manager conducts due diligence visits and interviews with each pricing vendor to verify the inputs utilized for each asset class. The due diligence visits include a review of the procedures performed by each vendor to ensure that pricing evaluations are representative of the price that would be received for a security in an orderly sale. Any pricing where the input is based solely on a broker price is deemed to be a Level 3 price. Intevac uses the pricing data obtained from its outside investment manager as the primary input to make its assessments and determinations as to the ultimate valuation of the above-mentioned securities and has not made, during the periods presented, any material adjustments to such inputs.

The following table represents the fair value hierarchy of Intevac’s available-for-sale securities measured at fair value on a recurring basis as of September 30, 2017.

	Fair Value Measurements at September 30, 2017
	Total		Level 1		Level 2
	(In thousands)
Recurring fair value measurements:
Available-for-sale securities
Money market funds	$	5,038	$	5,038	$	—
U.S. treasury and agency securities		6,892		4,865		2,027
Certificates of deposit		4,498		—		4,498
Commercial paper		1,990		—		1,990
Corporate bonds and medium-term notes		9,821		—		9,821
Municipal bonds		1,001		—		1,001
Total recurring fair value measurements	$	29,240	$	9,903	$	19,337

XML

Derivative Instruments

9 Months Ended

Sep. 30, 2017

Derivative Instruments

10. Derivative Instruments

The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the re-measurement of certain monetary assets and liabilities denominated in foreign currencies and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. These derivatives are carried at fair value with changes recorded in interest income and other income (expense), net in the condensed consolidated statements of operations. Changes in the fair value of these derivatives are largely offset by re-measurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. The derivatives have original maturities of approximately 30 days.

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016:

	Notional Amounts				Derivative Liabilities
Derivative Instrument	September 30 2017		December 31, 2016		September 30, 2017					December 31, 2016
					Balance Sheet Line			Fair Value		Balance Sheet Line			Fair Value
	(in thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	1,418	$	1,146		(a	)	$	2		(a	)	$	8
Total Hedges	$	1,418	$	1,146				$	2				$	8

(a) Other accrued liabilities

XML

Equity

9 Months Ended

Sep. 30, 2017

Equity

11. Equity

Stock Repurchase Program

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. At September 30, 2017, $1.5 million remains available for future stock repurchases under the repurchase program. Intevac did not make any stock repurchases during the three and nine months ended September 30, 2017 and October 1, 2016, respectively.

Intevac records treasury stock purchases under the cost method using the first-in, first-out (FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost are credited to additional paid-in capital. If Intevac reissues treasury stock at an amount below its acquisition cost and additional paid-in capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against retained earnings.

Accumulated Other Comprehensive Income

The changes in accumulated other comprehensive income by component for the three and nine months ended September 30, 2017 and October 1, 2016, are as follows.

	Three Months Ended									Nine Months Ended
	September 30, 2017
	Foreign currency			Unrealized holding losses on available-for-sale investments			Total			Foreign currency		Unrealized holding losses on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	418		$	(19	)	$	399		$	343	$	(22	)	$	321
Other comprehensive income before reclassification		39			5			44			114		8			122
Amounts reclassified from other comprehensive income		—			—			—			—		—			—
Net current-period other comprehensive income		39			5			44			114		8			122
Ending balance	$	457		$	(14	)	$	443		$	457	$	(14	)	$	443
	Three Months Ended									Nine Months Ended
	October 1, 2016
	Foreign currency			Unrealized holding gains on available-for-sale investments			Total			Foreign currency		Unrealized holding gains on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	474		$	17		$	491		$	452	$	(40	)	$	412
Other comprehensive income (loss) before reclassification		(17	)		(16	)		(33	)		5		41			46
Amounts reclassified from other comprehensive income		—			—			—			—		—			—
Net current-period other comprehensive income (loss)		(17	)		(16	)		(33	)		5		41			46
Ending balance	$	457		$	1		$	458		$	457	$	1		$	458

XML

Net Income (Loss) Per Share

9 Months Ended

Sep. 30, 2017

Net Income (Loss) Per Share

12. Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share:

	Three Months Ended					Nine Months Ended
	September 30, 2017		October 1, 2016			September 30, 2017		October 1, 2016
	(In thousands, except per share amounts)
Net income (loss)	$	1,230	$	(481	)	$	4,159	$	(10,276	)
Weighted-average shares – basic		21,714		20,869			21,475		20,704
Effect of dilutive potential common shares		1,256		—			1,514		—
Weighted-average shares – diluted		22,970		20,869			22,989		20,704
Net income (loss) per share – basic	$	0.06	$	(0.02	)	$	0.19	$	(0.50	)
Net income (loss) per share –diluted	$	0.05	$	(0.02	)	$	0.18	$	(0.50	)

The following potentially dilutive securities were excluded (as common stock equivalents) from the computation of diluted net income (loss) per share for the periods presented as their effect would have been antidilutive:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Stock options to purchase common stock		826		2,743		834		2,743
RSUs		—		955		—		955
Employee stock purchase plan		—		82		—		82

XML

Segment Reporting

9 Months Ended

Sep. 30, 2017

Segment Reporting

13. Segment Reporting

Intevac’s two reportable segments are: Thin-film Equipment and Photonics. Intevac’s chief operating decision-maker has been identified as the President and CEO, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Segment information is presented based upon Intevac’s management organization structure as of September 30, 2017 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to the reportable segments disclosed.

Each reportable segment is separately managed and has separate financial results that are reviewed by Intevac’s chief operating decision-maker. Each reportable segment contains closely related products that are unique to the particular segment. Segment operating profit is determined based upon internal performance measures used by the chief operating decision-maker.

Intevac derives the segment results from its internal management reporting system. The accounting policies Intevac uses to derive reportable segment results are substantially the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics, including orders, net revenues and operating income. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. Intevac manages certain operating expenses separately at the corporate level. Intevac allocates certain of these corporate expenses to the segments in an amount equal to 3% of net revenues. Segment operating income excludes interest income/expense and other financial charges and income taxes according to how a particular reportable segment’s management is measured. Management does not consider impairment charges, gains and losses on divestitures and sales of intellectual property, and unallocated costs in measuring the performance of the reportable segments.

The Thin-film Equipment segment designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the hard drive, solar cell and DCP industries, as well as other adjacent thin-film markets.

The Photonics segment develops compact, cost-effective, high-sensitivity digital-optical products for the capture and display of low-light images. Intevac provides sensors, cameras and systems for government applications such as night vision.

Information for each reportable segment for the three and nine months ended September 30, 2017 and October 1, 2016 is as follows:

Net Revenues

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Thin-film Equipment	$	17,177	$	14,272	$	61,087	$	25,941
Photonics		9,549		8,287		26,990		25,201
Total segment net revenues	$	26,726	$	22,559	$	88,077	$	51,142

Operating Income (Loss)

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
	(In thousands)
Thin-film Equipment	$	1,213		$	(998	)	$	4,821		$	(10,117	)
Photonics		1,417			1,737			3,646			3,656
Total segment operating income (loss)		2,630			739			8,467			(6,461	)
Unallocated costs		(1,362	)		(1,063	)		(3,768	)		(3,986	)
Income (loss) from operations		1,268			(324	)		4,699			(10,447	)
Interest income and other income (expense), net		28			60			265			184
Income (loss) before income taxes	$	1,296		$	(264	)	$	4,964		$	(10,263	)

Total assets for each reportable segment as of September 30, 2017 and December 31, 2016 are as follows:

Assets

	September 30, 2017		December 31, 2016
	(In thousands)
Thin-film Equipment	$	52,620	$	39,503
Photonics		16,563		16,071
Total segment assets		69,183		55,574
Cash, cash equivalents and investments		43,399		48,238
Restricted cash		1,400		1,602
Deferred income taxes		4		3
Other current assets		1,024		997
Common property, plant and equipment		1,698		1,039
Other assets		724		871
Consolidated total assets	$	117,432	$	108,324

XML

Income Taxes

9 Months Ended

Sep. 30, 2017

Income Taxes

14. Income Taxes

Intevac recorded income tax provisions of $66,000 and $805,000 for the three and nine months ended September 30, 2017, respectively, and $217,000 and $13,000 for the three and nine months ended October 1, 2016, respectively. The income tax provision for the nine months ended September 30, 2017 includes $506,000 for withholding taxes on royalties payable to the United States from Intevac’s Singapore subsidiary and $200,000 for audit considerations in foreign jurisdictions, both recorded as discrete items. The income tax provisions for the three and nine month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. Intevac did not recognize benefits on the U.S. net operating loss for the three and nine month period ended September 30, 2017 due to having full valuation allowances on the U.S. deferred tax assets. Intevac did not recognize benefits on the U.S. net operating loss or on the Singapore net operating loss for the three and nine month period ended October 1, 2016 due to having full valuation allowances on the U.S. deferred tax assets and on the Singapore deferred tax assets. Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, the utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

The Inland Revenue Authority of Singapore (“IRAS”) is currently conducting a review of the fiscal 2009 through 2012 tax returns of the Company’s wholly-owned subsidiary, Intevac Asia Pte. Ltd. IRAS has challenged the Company’s tax position with respect to certain aspects of the Company’s transfer pricing. Under Singapore tax law, the Company must pay all contested taxes and the related interest to have the right to defend its position. The contested tax deposits of $724,000 at September 30, 2017 and $871,000 at December 31, 2016 are included in other long-term assets on the condensed consolidated balance sheets. The Company’s management and its advisors continue to believe that the Company is “more likely than not” to successfully defend that the tax treatment was proper and in accordance with Singapore tax regulations. Presently, there are no other active income tax examinations in the jurisdictions where Intevac operates.

XML

Contingencies

9 Months Ended

Sep. 30, 2017

Contingencies

15. Contingencies

From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.

XML

Inventories (Tables)

9 Months Ended

Sep. 30, 2017

Summary of Inventories

Inventories are stated at the lower of average cost or market and consist of the following:

	September 30,		December 31,
	2017		2016
	(In thousands)
Raw materials	$	16,385	$	10,290
Work-in-progress		12,452		6,470
Finished goods		3,744		8,116
	$	32,581	$	24,876

XML

Equity-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2017

Effect of Recording Equity-Based Compensation

The effect of recording equity-based compensation for the three and nine months ended September 30, 2017 and October 1, 2016 was as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Equity-based compensation by type of award:
Stock options	$	350	$	211	$	808	$	696
RSUs		731		543		1,943		1,657
ESPP awards		67		151		261		543
Total equity-based compensation	$	1,148	$	905	$	3,012	$	2,896

Option Activity and Changes

Option activity as of September 30, 2017 and changes during the nine months ended September 30, 2017 were as follows:

	Shares			Weighted Average Exercise Price
Options outstanding at December 31, 2016		2,740,364		$	7.00
Options granted		413,075		$	12.33
Options cancelled and forfeited		(61,753	)	$	12.07
Options exercised		(115,273	)	$	6.88
Options outstanding at September 30, 2017		2,976,413		$	7.64
Options exercisable at September 30, 2017		2,127,940		$	7.16

Employee Stock Options Weighted-Average Assumptions

Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
Stock Options:
Weighted-average fair value of grants per share	$	3.89		$	1.90		$	4.54		$	1.75
Expected volatility		42.10	%		40.53	%		40.54	%		44.00	%
Risk free interest rate		1.84	%		0.97	%		1.77	%		0.94	%
Expected term of options (in years)		4.08			3.96			4.10			4.29
Dividend yield		None			None			None			None
	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
Stock Purchase Rights:
Weighted-average fair value of grants per share	$	2.76		$	1.69		$	2.75		$	1.55
Expected volatility		48.59	%		37.51	%		43.51	%		39.22	%
Risk free interest rate		1.36	%		0.63	%		1.22	%		0.75	%
Expected term of purchase rights (in years)		0.50			1.00			0.65			1.87
Dividend yield		None			None			None			None

Summary of Restricted Stock Units Activity

A summary of the RSU activity is as follows:

	Shares			Weighted Average Grant Date Fair Value
Non-vested RSUs at December 31, 2016		949,455		$	4.64
Granted		363,846		$	11.44
Vested		(500,621	)	$	4.46
Cancelled and forfeited		(14,292	)	$	7.97
Non-vested RSUs at September 30, 2017		798,388		$	7.79

Weighted Average Fair Value of Market Condition Based RSUs

Intevac estimated the weighted-average fair value of market condition-based RSUs using the following weighted-average assumptions:

	Nine Months Ended October 1, 2016
Weighted-average fair value of grants per share	$	2.46
Expected volatility		47.65	%
Risk free interest rate		1.35	%
Expected term (in years)		4.79
Dividend yield		None

XML

Purchased Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2017

Details of Finite-lived Intangible Assets by Segment

Details of finite-lived intangible assets by segment as of September 30, 2017 are as follows.

	September 30, 2017
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands)
Equipment	$	7,172	$	(5,648	)	$	1,524
Photonics		1,215		(1,077	)		138
	$	8,387	$	(6,725	)	$	1,662

Future Amortization Expense

As of September 30, 2017, future amortization expense is expected to be as follows.

(In thousands)
2017	$	159
2018		615
2019		615
2020		273
	$	1,662

XML

Acquisition-Related Contingent Consideration (Tables)

9 Months Ended

Sep. 30, 2017

Reconciliation of Change in Fair Value Measurement of Contingent Consideration Liability

The following table represents a reconciliation of the change in the fair value measurement of the contingent consideration liability for the three and nine month periods ended September 30, 2017 and October 1, 2016:

	Three Months Ended					Nine Months Ended
	September 30, 2017			October 1, 2016		September 30, 2017			October 1, 2016
	(In thousands)
Opening balance	$	859		$	748	$	759		$	890
Changes in fair value		(283	)		52		(181	)		(90	)
Cash payments made		(172	)		—		(174	)		—
Closing balance	$	404		$	800	$	404		$	800

Balance Sheet Classification of Contingent Consideration Liability

The following table displays the balance sheet classification of the contingent consideration liability account at September 30, 2017 and at December 31, 2016:

	September 30,		December 31,
	2017		2016
	(In thousands)
Other accrued liabilities	$	36	$	329
Other long-term liabilities		368		430
Total acquisition-related contingent consideration	$	404	$	759

Quantitative Information of Significant Unobservable Inputs of Contingent Consideration Liability

The following table represents the quantitative range of the significant unobservable inputs used in the calculation of fair value of the continent consideration liability as of September 30, 2017. Significant increases or decreases in any of these inputs in isolation would result in a significantly lower or higher fair value measurement.

	Quantitative Information about Level 3 Fair Value Measurements at September 30, 2017
	Fair Value		Valuation Technique	Unobservable Input	Range (Weighted Average)
	(In thousands, except for percentages)
Revenue Earnout	$	404	Discounted cash flow	Weighted average cost of capital Probability weighting of achieving revenue forecasts	11.9% 10.0% - 80.0% (30.0%)

XML

Warranty (Tables)

9 Months Ended

Sep. 30, 2017

Activity in Warranty Provision Account

The following table displays the activity in the warranty provision account for the three and nine months ended September 30, 2017 and October 1, 2016:

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
	(In thousands)
Opening balance	$	1,220		$	592		$	1,007		$	982
Expenditures incurred under warranties		(360	)		(80	)		(640	)		(384	)
Accruals for product warranties issued during the reporting period		169			320			675			494
Adjustments to previously existing warranty accruals		106			(110	)		93			(370	)
Closing balance	$	1,135		$	722		$	1,135		$	722

The following table displays the balance sheet classification of the warranty provision account at September 30, 2017 and at December 31, 2016:

	September 30, 2017		December 31, 2016
	(In thousands)
Other accrued liabilities	$	915	$	829
Other long-term liabilities		220		178
Total warranty provision	$	1,135	$	1,007

XML

Cash, Cash Equivalents and Investments (Tables)

9 Months Ended

Sep. 30, 2017

Cash, Cash Equivalents and Short-Term Investments and Long-Term Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

	September 30, 2017
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(In thousands)
Cash and cash equivalents:
Cash	$	14,159	$	—	$	—	$	14,159
Money market funds		5,038		—		—		5,038
Total cash and cash equivalents	$	19,197	$	—	$	—	$	19,197
Short-term investments:
Certificates of deposit	$	4,498	$	1	$	1	$	4,498
Commercial paper		1,990		—		—		1,990
Corporate bonds and medium-term notes		6,252		1		5		6,248
Municipal bonds		1,004		—		3		1,001
U.S. treasury and agency securities		4,300		—		—		4,300
Total short-term investments	$	18,044	$	2	$	9	$	18,037
Long-term investments:
Corporate bonds and medium-term notes	$	3,576	$	—	$	3	$	3,573
U.S. treasury and agency securities		2,596		—		4		2,592
Total long-term investments	$	6,172	$	—	$	7	$	6,165
Total cash, cash equivalents, and investments	$	43,413	$	2	$	16	$	43,399
	December 31, 2016
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value
	(in thousands)
Cash and cash equivalents:
Cash	$	18,726	$	—	$	—	$	18,726
Money market funds		8,317		—		—		8,317
Total cash and cash equivalents	$	27,043	$	—	$	—	$	27,043
Short-term investments:
Commercial paper	$	1,992	$	—	$	1	$	1,991
Corporate bonds and medium-term notes		8,586		—		6		8,580
Municipal bonds		600		—		—		600
U.S. treasury and agency securities		6,432		—		1		6,431
Total short-term investments	$	17,610	$	—	$	8	$	17,602
Long-term investments:
Corporate bonds and medium-term notes	$	2,510	$	—	$	11	$	2,499
Municipal bonds		500		—		4		496
U.S. treasury and agency securities		597		1		—		598
Total long-term investments	$	3,607	$	1	$	15	$	3,593
Total cash, cash equivalents, and investments	$	48,260	$	1	$	23	$	48,238

Contractual Maturities of Available-for-Sale Securities

The contractual maturities of available-for-sale securities at September 30, 2017 are presented in the following table.

	Amortized Cost		Fair Value
	(In thousands)
Due in one year or less	$	23,082	$	23,075
Due after one through two years		6,172		6,165
	$	29,254	$	29,240

Fair Market Value of Investments with Unrealized Losses Not Deemed to be Other-Than Temporarily Impaired

The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of September 30, 2017.

	September 30, 2017
	In Loss Position for Less than 12 Months				In Loss Position for Greater than 12 Months
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses
	(In thousands)
Certificates of deposit	$	1,249	$	1	$	—	$	—
Corporate bonds and medium-term notes		5,882		7		1,200		1
Municipal bonds		504		1		497		2
U.S. treasury and agency securities		4,118		4		—		—
	$	11,753	$	13	$	1,697	$	3

Fair Value Hierarchy of Available-for-Sale Securities Measured at Fair Value on Recurring Basis

The following table represents the fair value hierarchy of Intevac’s available-for-sale securities measured at fair value on a recurring basis as of September 30, 2017.

	Fair Value Measurements at September 30, 2017
	Total		Level 1		Level 2
	(In thousands)
Recurring fair value measurements:
Available-for-sale securities
Money market funds	$	5,038	$	5,038	$	—
U.S. treasury and agency securities		6,892		4,865		2,027
Certificates of deposit		4,498		—		4,498
Commercial paper		1,990		—		1,990
Corporate bonds and medium-term notes		9,821		—		9,821
Municipal bonds		1,001		—		1,001
Total recurring fair value measurements	$	29,240	$	9,903	$	19,337

XML

Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2017

Summary of Outstanding Derivative Instruments on Gross Basis as Recorded in Consolidated Balance Sheets

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of September 30, 2017 and December 31, 2016:

	Notional Amounts				Derivative Liabilities
Derivative Instrument	September 30 2017		December 31, 2016		September 30, 2017					December 31, 2016
					Balance Sheet Line			Fair Value		Balance Sheet Line			Fair Value
	(in thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	1,418	$	1,146		(a	)	$	2		(a	)	$	8
Total Hedges	$	1,418	$	1,146				$	2				$	8

(a) Other accrued liabilities

XML

Equity (Tables)

9 Months Ended

Sep. 30, 2017

Change in Accumulated Other Comprehensive Income by Component

The changes in accumulated other comprehensive income by component for the three and nine months ended September 30, 2017 and October 1, 2016, are as follows.

	Three Months Ended									Nine Months Ended
	September 30, 2017
	Foreign currency			Unrealized holding losses on available-for-sale investments			Total			Foreign currency		Unrealized holding losses on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	418		$	(19	)	$	399		$	343	$	(22	)	$	321
Other comprehensive income before reclassification		39			5			44			114		8			122
Amounts reclassified from other comprehensive income		—			—			—			—		—			—
Net current-period other comprehensive income		39			5			44			114		8			122
Ending balance	$	457		$	(14	)	$	443		$	457	$	(14	)	$	443
	Three Months Ended									Nine Months Ended
	October 1, 2016
	Foreign currency			Unrealized holding gains on available-for-sale investments			Total			Foreign currency		Unrealized holding gains on available-for-sale investments			Total
	(In thousands)
Beginning balance	$	474		$	17		$	491		$	452	$	(40	)	$	412
Other comprehensive income (loss) before reclassification		(17	)		(16	)		(33	)		5		41			46
Amounts reclassified from other comprehensive income		—			—			—			—		—			—
Net current-period other comprehensive income (loss)		(17	)		(16	)		(33	)		5		41			46
Ending balance	$	457		$	1		$	458		$	457	$	1		$	458

XML

Net Income (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2017

Computation of Basic and Diluted Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share:

	Three Months Ended					Nine Months Ended
	September 30, 2017		October 1, 2016			September 30, 2017		October 1, 2016
	(In thousands, except per share amounts)
Net income (loss)	$	1,230	$	(481	)	$	4,159	$	(10,276	)
Weighted-average shares – basic		21,714		20,869			21,475		20,704
Effect of dilutive potential common shares		1,256		—			1,514		—
Weighted-average shares – diluted		22,970		20,869			22,989		20,704
Net income (loss) per share – basic	$	0.06	$	(0.02	)	$	0.19	$	(0.50	)
Net income (loss) per share –diluted	$	0.05	$	(0.02	)	$	0.18	$	(0.50	)

Antidilutive Securities Excluded from Computation of Diluted Net Income (Loss) Per Share

The following potentially dilutive securities were excluded (as common stock equivalents) from the computation of diluted net income (loss) per share for the periods presented as their effect would have been antidilutive:

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Stock options to purchase common stock		826		2,743		834		2,743
RSUs		—		955		—		955
Employee stock purchase plan		—		82		—		82

XML

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2017

Information for Each Reportable Segment

Information for each reportable segment for the three and nine months ended September 30, 2017 and October 1, 2016 is as follows:

Net Revenues

	Three Months Ended				Nine Months Ended
	September 30, 2017		October 1, 2016		September 30, 2017		October 1, 2016
	(In thousands)
Thin-film Equipment	$	17,177	$	14,272	$	61,087	$	25,941
Photonics		9,549		8,287		26,990		25,201
Total segment net revenues	$	26,726	$	22,559	$	88,077	$	51,142

Operating Income (Loss)

	Three Months Ended						Nine Months Ended
	September 30, 2017			October 1, 2016			September 30, 2017			October 1, 2016
	(In thousands)
Thin-film Equipment	$	1,213		$	(998	)	$	4,821		$	(10,117	)
Photonics		1,417			1,737			3,646			3,656
Total segment operating income (loss)		2,630			739			8,467			(6,461	)
Unallocated costs		(1,362	)		(1,063	)		(3,768	)		(3,986	)
Income (loss) from operations		1,268			(324	)		4,699			(10,447	)
Interest income and other income (expense), net		28			60			265			184
Income (loss) before income taxes	$	1,296		$	(264	)	$	4,964		$	(10,263	)

Assets for Each Reportable Segment

Total assets for each reportable segment as of September 30, 2017 and December 31, 2016 are as follows:

Assets

	September 30, 2017		December 31, 2016
	(In thousands)
Thin-film Equipment	$	52,620	$	39,503
Photonics		16,563		16,071
Total segment assets		69,183		55,574
Cash, cash equivalents and investments		43,399		48,238
Restricted cash		1,400		1,602
Deferred income taxes		4		3
Other current assets		1,024		997
Common property, plant and equipment		1,698		1,039
Other assets		724		871
Consolidated total assets	$	117,432	$	108,324

XML

Recent Accounting Pronouncements - Additional Information (Detail) $ in Millions	Jan. 01, 2017 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect of change in accumulated deficit	$ 1.1

XML

Inventories Stated at Lower of Average Cost or Market (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Inventory [Line Items]
Raw materials	$ 16,385	$ 10,290
Work-in-progress	12,452	6,470
Finished goods	3,744	8,116
Inventories	$ 32,581	$ 24,876

XML

Equity-Based Compensation - Additional information (Detail)	1 Months Ended		3 Months Ended	9 Months Ended
	Feb. 28, 2017 Employee $ / shares shares	Feb. 29, 2016 Employee $ / shares shares	Oct. 01, 2016 USD ($)	Sep. 30, 2017 USD ($) shares	Oct. 01, 2016 USD ($) shares	Jan. 01, 2017 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Purchase of common stock through payroll deductions				85.00%
Offering periods				2 years
Purchase intervals of a series				6 months
Maximum employee salary withholdings for purchase of common stock under the terms of the ESPP				15.00%
Cumulative effect of change in accumulated deficit | $						$ 1,100,000
Number of shares issued under employee stock purchase plan				405,659
RSU conversion ratio				100.00%
Annual incentive plan stock awards granted				413,075
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of share awards granted				363,846
Annual incentive plan equity-based compensation expense | $			$ 120,000	$ 102,000	$ 364,000
Number of participants in restricted stock grants awarded | Employee	33	34
Annual incentive plan stock awards granted	134,000	266,000
Weighted-average fair value of grants per share | $ / shares	$ 9.63	$ 4.40
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period				3 years
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award, vesting period				4 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of share awards granted					125,000
Derived service period					2 years 9 months 18 days

XML

Effect of Recording Equity-Based Compensation (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	$ 1,148	$ 905	$ 3,012	$ 2,896
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	350	211	808	696
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	731	543	1,943	1,657
Employee stock purchase plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based compensation	$ 67	$ 151	$ 261	$ 543

XML

Option Activity and Changes (Detail)	9 Months Ended
	Sep. 30, 2017 $ / shares shares
Shares
Options outstanding at December 31, 2016 | shares	2,740,364
Options granted | shares	413,075
Options cancelled and forfeited | shares	(61,753)
Options exercised | shares	(115,273)
Options outstanding at September 30, 2017 | shares	2,976,413
Options exercisable at September 30, 2017 | shares	2,127,940
Weighted Average Exercise Price
Options outstanding at December 31, 2016 | $ / shares	$ 7.00
Options granted | $ / shares	12.33
Options cancelled and forfeited | $ / shares	12.07
Options exercised | $ / shares	6.88
Options outstanding at September 30, 2017 | $ / shares	7.64
Options exercisable at September 30, 2017 | $ / shares	$ 7.16

XML

Weighted-Average Fair Value of Stock Options and Employee Stock Purchase Rights using Weighted-Average Assumptions (Detail) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Stock Options
Weighted-average assumptions
Weighted-average fair value of grants per share	$ 3.89	$ 1.90	$ 4.54	$ 1.75
Expected volatility	42.10%	40.53%	40.54%	44.00%
Risk free interest rate	1.84%	0.97%	1.77%	0.94%
Expected term of options (in years)	4 years 29 days	3 years 11 months 15 days	4 years 1 month 6 days	4 years 3 months 15 days
Dividend yield	0.00%	0.00%	0.00%	0.00%
Stock Purchase Rights
Weighted-average assumptions
Weighted-average fair value of grants per share	$ 2.76	$ 1.69	$ 2.75	$ 1.55
Expected volatility	48.59%	37.51%	43.51%	39.22%
Risk free interest rate	1.36%	0.63%	1.22%	0.75%
Expected term of options (in years)	6 months	1 year	7 months 24 days	1 year 10 months 14 days
Dividend yield	0.00%	0.00%	0.00%	0.00%

XML

Summary of Restricted Stock Units Activity (Detail) - Restricted Stock Units (RSUs)	9 Months Ended
	Sep. 30, 2017 $ / shares shares
Shares
Non-vested RSUs at December 31, 2016 | shares	949,455
Granted | shares	363,846
Vested | shares	(500,621)
Cancelled and forfeited | shares	(14,292)
Non-vested RSUs at September 30, 2017 | shares	798,388
Weighted Average Grant Date Fair Value
Non-vested RSUs at December 31, 2016 | $ / shares	$ 4.64
Granted | $ / shares	11.44
Vested | $ / shares	4.46
Cancelled and forfeited | $ / shares	7.97
Non-vested RSUs at September 30, 2017 | $ / shares	$ 7.79

XML

Weighted Average Fair Value of Market Condition Based RSUs (Detail) - Restricted Stock	9 Months Ended
	Oct. 01, 2016 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average fair value of grants per share	$ 2.46
Expected volatility	47.65%
Risk free interest rate	1.35%
Expected term (in years)	4 years 9 months 15 days
Dividend yield	0.00%

XML

Details of Finite-lived Intangible Assets by Segment (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
Finite Lived, Gross Carrying Amount	$ 8,387
Accumulated Amortization	(6,725)	$ (6,129)
Finite Lived, Net Carrying Amount	1,662	$ 2,258
Thin-film Equipment Segment
Finite-Lived Intangible Assets [Line Items]
Finite Lived, Gross Carrying Amount	7,172
Accumulated Amortization	(5,648)
Finite Lived, Net Carrying Amount	1,524
Photonics
Finite-Lived Intangible Assets [Line Items]
Finite Lived, Gross Carrying Amount	1,215
Accumulated Amortization	(1,077)
Finite Lived, Net Carrying Amount	$ 138

XML

Purchased Intangible Assets - Additional Information (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2017
Acquired Finite-Lived Intangible Assets [Line Items]
Total amortization expense of finite-lived intangibles	$ 169,000	$ 596,000

XML

Future Amortization Expense (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
2017	$ 159
2018	615
2019	615
2020	273
Finite Lived, Net Carrying Amount	$ 1,662	$ 2,258

XML

Acquisition-Related Contingent Consideration - Additional Information (Detail) $ in Millions	Nov. 19, 2010 USD ($)
Solar Implant Technologies | Revenue Earnout
Business Acquisition [Line Items]
Maximum amount of cash potentially earned in contingent compensation arrangements	$ 9.0

XML

Reconciliation of Change in Fair Value Measurement of Contingent Consideration Liability (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Business Acquisition, Contingent Consideration [Line Items]
Opening balance	$ 859	$ 748	$ 759	$ 890
Changes in fair value	(283)	52	(181)	(90)
Cash payments made	(172)		(174)
Closing balance	$ 404	$ 800	$ 404	$ 800

XML

Balance Sheet Classification of Contingent Consideration Liability (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Business Combination, Transactions [Line Items]
Other accrued liabilities	$ 404	$ 759
Other accrued liabilities
Business Combination, Transactions [Line Items]
Other accrued liabilities	36	329
Other long-term liabilities
Business Combination, Transactions [Line Items]
Other accrued liabilities	$ 368	$ 430

XML

Quantitative Range of Significant Unobservable Inputs Used in Calculation of Fair Value of Continent Consideration Liability (Detail) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
Business Acquisition, Contingent Consideration [Line Items]
Fair Value	$ 404	$ 759
Fair Value, Inputs, Level 3 | Revenue Earnout
Business Acquisition, Contingent Consideration [Line Items]
Valuation technique	Discounted cash flow
Fair Value	$ 404
Fair Value, Inputs, Level 3 | Revenue Earnout | Weighted Average
Business Acquisition, Contingent Consideration [Line Items]
Weighted average cost of capital	11.90%
Probability weighting of achieving revenue forecasts	30.00%
Fair Value, Inputs, Level 3 | Revenue Earnout | Minimum
Business Acquisition, Contingent Consideration [Line Items]
Probability weighting of achieving revenue forecasts	10.00%
Fair Value, Inputs, Level 3 | Revenue Earnout | Maximum
Business Acquisition, Contingent Consideration [Line Items]
Probability weighting of achieving revenue forecasts	80.00%

XML

Warranty - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2017
Warranties [Line Items]
Minimum product warranty range	12 months
Maximum product warranty range	24 months

XML

Warranty Provision Account (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Accrued Warranty [Line Items]
Opening balance	$ 1,220	$ 592	$ 1,007	$ 982
Expenditures incurred under warranties	(360)	(80)	(640)	(384)
Accruals for product warranties issued during the reporting period	169	320	675	494
Adjustments to previously existing warranty accruals	106	(110)	93	(370)
Closing balance	$ 1,135	$ 722	$ 1,135	$ 722

XML

Balance Sheet Classification of Warranty Provision Account (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Jul. 01, 2017	Dec. 31, 2016	Oct. 01, 2016	Jul. 02, 2016	Jan. 02, 2016
Product Warranty [Line Items]
Other accrued liabilities	$ 915		$ 829
Other long-term liabilities	220		178
Total warranty provision	$ 1,135	$ 1,220	$ 1,007	$ 722	$ 592	$ 982

XML

Guarantees - Additional Information (Detail) $ in Millions	Sep. 30, 2017 USD ($)
Guarantor Obligations [Line Items]
Letters of credit and bank guarantees outstanding, amount	$ 1.4
Letters of credit and bank guarantees collateralized by restricted cash	$ 1.4

XML

Cash, Cash Equivalents and Short-Term Investments and Long-Term Investments (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 43,413	$ 48,260
Unrealized Holdings Gains	2	1
Unrealized Holdings Losses	16	23
Fair Value	43,399	48,238
Cash and Cash Equivalents
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	19,197	27,043
Fair Value	19,197	27,043
Cash and Cash Equivalents | Cash
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	14,159	18,726
Fair Value	14,159	18,726
Cash and Cash Equivalents | Money market funds
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	5,038	8,317
Fair Value	5,038	8,317
Short-term Investments
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	18,044	17,610
Unrealized Holdings Gains	2
Unrealized Holdings Losses	9	8
Fair Value	18,037	17,602
Short-term Investments | Municipal bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,004	600
Unrealized Holdings Losses	3
Fair Value	1,001	600
Short-term Investments | U.S. treasury and agency securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	4,300	6,432
Unrealized Holdings Losses		1
Fair Value	4,300	6,431
Short-term Investments | Corporate bonds and medium-term notes
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	6,252	8,586
Unrealized Holdings Gains	1
Unrealized Holdings Losses	5	6
Fair Value	6,248	8,580
Short-term Investments | Certificate of deposit
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	4,498
Unrealized Holdings Gains	1
Unrealized Holdings Losses	1
Fair Value	4,498
Short-term Investments | Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,990	1,992
Unrealized Holdings Losses		1
Fair Value	1,990	1,991
Other Long-term Investments
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	6,172	3,607
Unrealized Holdings Gains		1
Unrealized Holdings Losses	7	15
Fair Value	6,165	3,593
Other Long-term Investments | Municipal bonds
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost		500
Unrealized Holdings Losses		4
Fair Value		496
Other Long-term Investments | U.S. treasury and agency securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	2,596	597
Unrealized Holdings Gains		1
Unrealized Holdings Losses	4
Fair Value	2,592	598
Other Long-term Investments | Corporate bonds and medium-term notes
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	3,576	2,510
Unrealized Holdings Losses	3	11
Fair Value	$ 3,573	$ 2,499

XML

Contractual Maturities of Available-For-Sale Securities (Detail) $ in Thousands	Sep. 30, 2017 USD ($)
Amortized Cost
Amortized Cost, Due in one year or less	$ 23,082
Amortized Cost, Due after one through two years	6,172
Amortized Cost	29,254
Fair Value
Fair Value, Due in one year or less	23,075
Fair Value, Due after one through two years	6,165
Fair Value	$ 29,240

XML

Fair Market Value of Investments with Unrealized Losses Not Deemed to be Other-Than Temporarily Impaired (Detail) $ in Thousands	Sep. 30, 2017 USD ($)
Schedule of Available-for-sale Securities [Line Items]
Unrealized Loss Position, Less than 12 Months, Fair Value	$ 11,753
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	13
Unrealized Loss Position, Greater than 12 Months, Fair Value	1,697
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses	3
Certificate of deposit
Schedule of Available-for-sale Securities [Line Items]
Unrealized Loss Position, Less than 12 Months, Fair Value	1,249
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	1
Corporate bonds and medium-term notes
Schedule of Available-for-sale Securities [Line Items]
Unrealized Loss Position, Less than 12 Months, Fair Value	5,882
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	7
Unrealized Loss Position, Greater than 12 Months, Fair Value	1,200
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses	1
Municipal bonds
Schedule of Available-for-sale Securities [Line Items]
Unrealized Loss Position, Less than 12 Months, Fair Value	504
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	1
Unrealized Loss Position, Greater than 12 Months, Fair Value	497
Unrealized Loss Position, Greater than 12 Months, Gross Unrealized Losses	2
U.S. treasury and agency securities
Schedule of Available-for-sale Securities [Line Items]
Unrealized Loss Position, Less than 12 Months, Fair Value	4,118
Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses	$ 4

XML

Fair Value Hierarchy of Available-for-Sale Securities Measured at Fair Value on Recurring Basis (Detail) $ in Thousands	Sep. 30, 2017 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	$ 29,240
Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	29,240
Fair Value, Measurements, Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	5,038
Fair Value, Measurements, Recurring | Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	4,498
Fair Value, Measurements, Recurring | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	1,990
Fair Value, Measurements, Recurring | U.S. treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	6,892
Fair Value, Measurements, Recurring | Corporate bonds and medium-term notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	9,821
Fair Value, Measurements, Recurring | Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	1,001
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	9,903
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	5,038
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | U.S. treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	4,865
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	19,337
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Certificate of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	4,498
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	1,990
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | U.S. treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	2,027
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Corporate bonds and medium-term notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	9,821
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Municipal bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total recurring fair value measurements	$ 1,001

XML

Derivative Instruments - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2017
Derivative [Line Items]
Maturity of foreign currency derivative	30 days

XML

Summary of Outstanding Derivative Instruments on Gross Basis as Recorded in Consolidated Balance Sheets (Detail) - Undesignated Hedges - USD ($) $ in Thousands		Sep. 30, 2017	Dec. 31, 2016
Derivatives, Fair Value [Line Items]
Notional Amounts		$ 1,418	$ 1,146
Derivative Liabilities		2	8
Forward foreign currency contracts
Derivatives, Fair Value [Line Items]
Notional Amounts		1,418	1,146
Derivative Liabilities	[1]	$ 2	$ 8

[1] Other accrued liabilities

XML

Equity - Additional Information (Detail) - USD ($) shares in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016	Nov. 21, 2013
Equity, Class of Treasury Stock [Line Items]
Stock repurchase authorized amount					$ 30,000,000
Stock repurchase remained available for future stock repurchase	$ 1,500,000		$ 1,500,000
Stock repurchased	0	0	0	0

XML

Changes in Accumulated Other Comprehensive Income by Component (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance			$ 73,266
Other comprehensive income (loss) before reclassification	$ 44	$ (33)	122	$ 46
Amounts reclassified from other comprehensive income	0	0	0	0
Other comprehensive income (loss), net of tax	44	(33)	122	46
Ending balance	81,418		81,418
Foreign currency
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	418	474	343	452
Other comprehensive income (loss) before reclassification	39	(17)	114	5
Amounts reclassified from other comprehensive income	0	0	0	0
Other comprehensive income (loss), net of tax	39	(17)	114	5
Ending balance	457	457	457	457
Unrealized holding losses on available-for-sale investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(19)	17	(22)	(40)
Other comprehensive income (loss) before reclassification	5	(16)	8	41
Amounts reclassified from other comprehensive income	0	0	0	0
Other comprehensive income (loss), net of tax	5	(16)	8	41
Ending balance	(14)	1	(14)	1
Accumulated other comprehensive income
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	399	491	321	412
Amounts reclassified from other comprehensive income	0	0	0	0
Ending balance	$ 443	$ 458	$ 443	$ 458

XML

Computation of Basic and Diluted Net Income (Loss) Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Schedule Of Computation Of Basic And Diluted Earnings Per Common Share [Line Items]
Net income (loss)	$ 1,230	$ (481)	$ 4,159	$ (10,276)
Weighted-average shares - basic	21,714	20,869	21,475	20,704
Effect of dilutive potential common shares	1,256		1,514
Weighted-average shares - diluted	22,970	20,869	22,989	20,704
Net income (loss) per share - basic	$ 0.06	$ (0.02)	$ 0.19	$ (0.50)
Net income (loss) per share - diluted	$ 0.05	$ (0.02)	$ 0.18	$ (0.50)

XML

Antidilutive Securities Excluded from Computation of Diluted Net Income (Loss) Per Share (Detail) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net income (loss) per share	826	2,743	834	2,743
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net income (loss) per share		955		955
Employee stock purchase plan
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of diluted net income (loss) per share		82		82

XML

Segment Reporting - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2017 Segment
Segment Reporting Disclosure [Line Items]
Number of reportable segments	2
Allocation of corporate expenses to the segments	3.00%

XML

Information for Each Reportable Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016
Segment Reporting Information [Line Items]
Total segment net revenues	$ 26,726	$ 22,559	$ 88,077	$ 51,142
Income (loss) from operations	1,268	(324)	4,699	(10,447)
Interest income and other income (expense), net	28	60	265	184
Income (loss) before income taxes	1,296	(264)	4,964	(10,263)
Thin-film Equipment Segment
Segment Reporting Information [Line Items]
Total segment net revenues	17,177	14,272	61,087	25,941
Photonics
Segment Reporting Information [Line Items]
Total segment net revenues	9,549	8,287	26,990	25,201
Operating Segments
Segment Reporting Information [Line Items]
Income (loss) from operations	2,630	739	8,467	(6,461)
Operating Segments | Thin-film Equipment Segment
Segment Reporting Information [Line Items]
Income (loss) from operations	1,213	(998)	4,821	(10,117)
Operating Segments | Photonics
Segment Reporting Information [Line Items]
Income (loss) from operations	1,417	1,737	3,646	3,656
Unallocated Amount to Segment
Segment Reporting Information [Line Items]
Unallocated costs	$ (1,362)	$ (1,063)	$ (3,768)	$ (3,986)

XML

Assets for Each Reportable Segment (Detail) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Segment Reporting, Asset Reconciling Item [Line Items]
Cash, cash equivalents and investments	$ 43,399	$ 48,238
Restricted cash	1,400	1,602
Deferred income taxes	4	3
Other current assets	1,024	997
Common property, plant and equipment	1,698	1,039
Other assets	724	871
Consolidated total assets	117,432	108,324
Operating Segments
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	69,183	55,574
Operating Segments | Thin-film Equipment Segment
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	52,620	39,503
Operating Segments | Photonics
Segment Reporting, Asset Reconciling Item [Line Items]
Consolidated total assets	$ 16,563	$ 16,071

XML

Income Taxes - Additional Information (Detail) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016	Sep. 30, 2017	Oct. 01, 2016	Dec. 31, 2016
Income Taxes [Line Items]
Provision for income taxes	$ 66,000	$ 217,000	$ 805,000	$ 13,000
Deposit for contested taxes and related interest	724,000		724,000		$ 871,000
Foreign Tax Authority
Income Taxes [Line Items]
Income tax charge (benefit)			200,000
Foreign Tax Authority | Singapore
Income Taxes [Line Items]
Income tax charge (benefit)			506,000
Inland Revenue, Singapore (IRAS)
Income Taxes [Line Items]
Deposit for contested taxes and related interest	$ 724,000		$ 724,000		$ 871,000